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Abstract 
Antimicrobial resistant (AMR) bacteria are increasing threats for human and veterinary 
medicine. Faecal Escherichia coli (E. coli) from preweaned dairy calves is often 
resistant to multiple antimicrobials and calves may therefore serve as reservoirs for 
these bacteria and their resistance genes. This thesis investigated the prevalence, risk 
factors, and spread of resistant E. coli on Swedish dairy farms, with special emphasis 
on quinolone resistant E. coli (QREC). Faecal samples from preweaned calves and 
post-partum cows were analysed for resistant E. coli and set in relation to potential risk 
factors. The farm environment was sampled to study the occurrence and spread of 
QREC.  
The occurrence of faecal resistant E. coli in calves was strongly age-dependent, but 
was also associated with herd size, milking system, calf housing, and geographic 
location of the farm. Treatment with some broad-spectrum antimicrobials in cows or 
calves increased the occurrence of resistant E. coli in calves. Feeding waste milk from 
cows treated with antimicrobials during lactation to calves increased the proportion of 
streptomycin and quinolone resistant E. coli in calves, but feeding waste colostrum 
from cows treated with antimicrobials at drying off had no effect on AMR E. coli. 
Feeding such colostrum or milk to calves was a common practice on Swedish dairy 
farms, in particular on farms in southern Sweden, on non-organic farms, and on farms 
with tie stall housing. On farms where QREC is common in faeces of calves, these 
bacteria were also widespread in the farm environment. In particular, the calf feed and 
water trough contained QREC. The same QREC genotype was found throughout the 
same and on different farms, suggesting contagious spread of QREC within and 
between farms. Fluoroquinolone treatment, WM feeding, group calving, poor farm 
hygiene, purchasing cattle or shared animal transports were some risk factors for 
increasing the occurrence of QREC on the farm.  
Altogether, the results indicate that proper biosecurity and improved hygiene, less 
exposure to broad-spectrum antimicrobials, and restrictive waste milk feeding may be 
important factors to reduce the burden of AMR E. coli on dairy farms.  
 
Keywords: Calf, Escherichia coli, antimicrobial resistance, waste milk, antimicrobials, 
quinolone resistance, genetic diversity, risk factor, spread 
Author’s address: Anna Duse, SLU, Department of Clinical Sciences, P.O. Box 7054, 
750 07 Uppsala, Sweden; Department of Animal Health and Antimicrobial Strategies, 
National Veterinary Institute, 751 89 Uppsala, Sweden  
E-mail: Anna.Duse@sva.se
4 
Dedication 
To my grandmother Ingrid, who passed away during the making of this book 
and never got to see me finish. I hope you get to watch the final while wearing 
the prettiest angel wings ever! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Whatever you do in life, surround yourself with smart people who'll argue 
with you.” 
John Wooden 
5 
Contents 
List of Publications 8 
Abbreviations 10 
1  Introduction 11 
1.1  General aspects of antimicrobial resistance 11 
1.1.1  Emergence and spread of antimicrobial resistance 12 
1.1.2  The role of commensal E. coli 14 
1.1.3  Antimicrobials and resistance of special concern 15 
1.2  Antimicrobial resistant faecal E. coli from dairy calves 16 
1.2.1  Occurrence of AMR E. coli in faeces of dairy cattle 16 
1.2.2  Factors affecting faecal AMR E. coli in preweaned dairy calves 16 
1.2.3  The age of the calf 17 
1.3  Dissemination of AMR E. coli on dairy farms 19 
1.4  Zoonotic aspects 20 
1.5  The current dairy cow sector in Sweden 21 
1.5.1  Usage of and prescription of antimicrobials 22 
1.5.2  Feeding milk to calves from cows treated with antimicrobials 24 
2  Aims of the thesis 27 
3  Materials and Methods 29 
3.1  Summary of the study designs 29 
3.2  Study populations 29 
3.3  Sampling procedures 31 
3.3.1  Faecal samples 31 
3.3.2  Environmental samples 31 
3.3.3  Milk samples 32 
3.3.4  Determination of farm hygiene 32 
3.4  Antimicrobial susceptibility testing 32 
3.4.1  Preparation of samples 32 
3.4.2  Selective media 33 
3.4.3  Broth microdilution 33 
3.5  Molecular typing methods 33 
3.5.1  Polymerase Chain Reaction 33 
3.5.2  Multiple-Locus Variable-number tandem repeat Analysis 33 
3.5.3  Sequencing of specific variants of ESBL and pAmpC genes 34 
3.6  Data from questionnaires and interviews 34 
6 
3.6.1  Paper I 34 
3.6.2  Paper II 34 
3.6.3  Paper III 35 
3.7  Data from other sources 35 
3.8  Statistical analysis 35 
4  Results 37 
4.1  Prevalence of AMR E. coli 37 
4.1.1  Selective plates 37 
4.1.2  Resistance in randomly selected E. coli isolates (paper II) 38 
4.2  Risk factors for AMR E. coli (paper II) 38 
4.3  Farming practices related to feeding waste milk 41 
4.4  Risk factors for QREC (paper III) 42 
4.5  Dissemination and genetic diversity of QREC (paper IV) 43 
4.5.1  QREC contamination of the farm environment and milk 43 
4.5.2  Genetic diversity and dissemination of QREC 44 
5  Discussion 45 
5.1  Factors related to the occurrence of AMR E. coli 45 
5.1.1  Age-related dynamics of AMR E. coli 45 
5.1.2  Antimicrobial use and its implications for AMR E. coli 47 
5.1.3  Waste milk feeding and its implications for AMR E. coli 50 
5.2  Factors related to the dissemination of AMR E. coli, with special 
reference to QREC 53 
5.2.1  Acquisition of QREC by calves 54 
5.2.2  Dissemination of AMR E. coli within farms 55 
5.2.3  Dissemination of AMR E. coli between farms 57 
5.3  Clinical importance of AMR E. coli on dairy farms 59 
5.4  Methodological considerations 59 
5.4.1  Study populations and study designs 60 
5.4.2  Collection of data on antimicrobial usage 61 
5.4.3  Limitations with questionnaire data 62 
5.4.4  Sampling considerations 62 
5.4.5  Methods for susceptibility testing 63 
6  Conclusions 65 
7  Practical recommendations 67 
8  Perspectives for the future 69 
7 
9  Populärvetenskaplig sammanfattning 73 
References 79 
Acknowledgements 93 
  
8 
List of Publications 
This thesis is based on the work contained in the following papers, referred to 
by Roman numerals in the text: 
I Duse A., Waller K.P., Emanuelson U., Unnerstad H.E., Persson Y., 
Bengtsson B. (2013). Farming practices in Sweden related to feeding milk 
and colostrum from cows treated with antimicrobials to dairy calves. Acta 
Veterinaria Scandinavica 55, 49. 
II Duse A., Waller K.P., Emanuelson U., Unnerstad H.E., Persson Y., 
Bengtsson B. (2015). Risk factors for antimicrobial resistance in fecal 
Escherichia coli from preweaned dairy calves. Journal of Dairy Science 
98(1), 500–516. 
III Duse A., Waller K.P., Emanuelson U., Unnerstad H.E., Persson Y., 
Bengtsson B. Risk factors for quinolone resistant Escherichia coli in faeces 
from preweaned dairy calves and post-partum dairy cows. (Submitted 
manuscript). 
IV Duse A., Waller K.P., Emanuelson U., Unnerstad H.E., Persson Y., 
Bengtsson B. Occurrence and spread of quinolone resistant Escherichia coli 
on Swedish dairy farms. (Manuscript). 
Papers I-II are reproduced with the permission of the publishers.
9 
 
The contribution of Anna Duse to the papers included in this thesis was as 
follows: 
I Was involved in the planning of the study. Developed the questionnaire 
with input from the co-authors and was responsible for the survey 
logistics. Analysed the results in collaboration with the supervisors. 
Performed the statistical analyses under supervision and wrote the 
manuscript with regular input from the co-authors.  
II Was involved in the planning of the practical study. Was responsible for 
the recruitment of herds and for the sampling logistics. Performed most 
laboratory work and analysed the results under supervision. Was 
responsible for writing and completing the manuscript with regular input 
from the co-authors.  
III Was involved in the research idea and planning of the study. Was 
responsible for the recruitment of herds and visited the herds. Contributed 
to laboratory work. Performed the statistical analyses under supervision 
and wrote the manuscript with regular input from the co-authors. 
IV Was involved in the research idea and planning of the study. Was 
responsible for the recruitment of herds and visited the herds. Contributed 
to laboratory work and performed all genotyping analyses. Performed the 
statistical analyses under supervision and wrote the manuscript with regular 
input from the co-authors. 
  
10 
Abbreviations 
AMR Antimicrobial resistant 
Amr Ampicillin resistant 
CFU Colony Forming Unit 
Cir Ciprofloxacin resistant 
Cmr Chloramphenicol resistant 
Ctxr Cefotaxime resistant 
DCT Dry cow therapy 
DHS Dihydrostreptomycin 
DI Diversity Index 
ESBL Extended Spectrum Betalactamases 
GI Gastrointestinal 
H-farm High farm (where QREC is common in faeces from calves)  
Kmr Kanamycin resistant 
L-farm Low farm (where QREC is rare in faeces from calves) 
MIC Minimum Inhibitory Concentration 
MLVA Multiple Locus Variable-number Tandem Repeat Analysis 
NADRS National Animal Disease Recording Scheme 
Nalr Nalidixic acid resistant 
PCR Polymerase Chain Reaction 
QREC Quinolone resistant Escherichia coli 
SEC Select E. coli Count 
Smr Streptomycin resistant 
SOMRS Swedish Official Milk Recording Scheme 
Sur Sulphametoxazole resistant 
Tcr Tetracycline resistant 
TWM Waste milk produced during ongoing treatment 
WC Waste colostrum  
WT Waste transition milk 
WWM Waste milk produced during the withdrawal period 
11 
1 Introduction 
 
Antimicrobial resistance is an increasing threat for human and animal health. 
Antimicrobial resistant (AMR) Escherichia coli from the gut of calves is 
normally harmless for the calf itself, but may cause intractable infections in the 
animal or its herd-mates. There is also a risk that AMR E. coli strains in the 
cattle population are transferred to humans by direct contact or via 
contaminated milk or meat products. Preweaned dairy calves often shed AMR 
E. coli in faeces. Many of these E. coli strains are multi-drug resistant, even 
when the calf has never been exposed to antimicrobials. Hence, calves may act 
as reservoirs for AMR E. coli causing intractable infections in animals and 
humans. The epidemiology of faecal AMR E. coli in calves is not yet fully 
understood and more knowledge is needed to define measures that could 
reduce the burden of AMR E. coli on dairy farms.  
This thesis investigates the prevalence, risk factors, and spread of faecal 
AMR E. coli in preweaned dairy calves in relation to farm and calf 
characteristics, usage of antimicrobials in the herd, management factors such as 
the feeding of milk from antimicrobial-treated cows to calves, and factors 
associated with within- and between- farm biosecurity. 
1.1 General aspects of antimicrobial resistance  
The global emergence of antimicrobial resistance is a rising concern for human 
health (WHO, 2012b). The consequences of antimicrobial resistance extend 
beyond treatment failures in individual cases. Without effective antimicrobials, 
important procedures such as major surgery, organ transplantation, and cancer 
chemotherapy will be hazardous (Cars et al., 2008; Laxminarayan et al., 2013). 
It has been estimated that by 2050, approximately ten million deaths per year 
will be due to infections with resistant bacteria. This means that the number of 
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deaths due to resistant bacteria will exceed the number of deaths due to cancer 
in 2050 (O’Neill, 2014). 
The consequences of antimicrobial resistance in animals are similar to those 
for humans, leading to increased suffering and mortality (Bengtsson & Greko, 
2014). However, future veterinary medicine has to rely mainly on the efficacy 
of already existing antimicrobials (Schwarz et al., 2001). Moreover, the World 
Health Organization has stated that some antimicrobials (fluoroquinolones, 
third and fourth generation cephalosporins and macrolides) should be reserved 
only for treating human infections (WHO, 2012a). It is also likely that any new 
antimicrobial will be reserved for human medicine (Schwarz et al., 2001; 
Bengtsson & Greko, 2014). Loss of effective treatment options for animals 
may not only lead to therapy failures, but also to decreased welfare and 
reduced productivity for food-producing animals, resulting in major setbacks 
for the animal and global food production (Bengtsson & Greko, 2014).  
1.1.1 Emergence and spread of antimicrobial resistance 
Emergence refers to the conversion from wild-type to resistance phenotypes, 
whereas spread refers to the dissemination of resistance between hosts and the 
environment, or spread of resistance determinants between bacteria. Often 
emergence and spread may overlap.  
Emergence 
Emergence of antimicrobial resistance is a normal step in bacterial evolution, 
as the survival of bacteria with the phenotypical traits best adapted to the 
current environment (Sykes, 2010). Exposure to antimicrobials imposes a 
selective pressure on the bacterial population, allowing only resistant 
subpopulations of bacteria to survive.  
Antimicrobial resistance can be intrinsic or acquired (Alekshun & Levy, 
2007). Intrinsic resistance is conferred by naturally occurring genes in the 
bacterium’s genome or by inherent characteristics of the bacterium, which 
allow tolerance to specific antimicrobials (Alekshun & Levy, 2007; Cox & 
Wright, 2013). Intrinsic resistance is common for all members of a bacterial 
species and is independent of the selective pressure from antimicrobials (Cox 
& Wright, 2013). Acquired resistance is when a particular bacterium obtains 
the ability to resist a specific antimicrobial agent to which it was previously 
susceptible (Alekshun & Levy, 2007). Unlike intrinsic resistance, acquired 
resistance traits are found only in some strains or subpopulations of a bacterial 
species (Alekshun & Levy, 2007).  
There are two mechanisms by which bacteria acquire resistance - by 
spontaneous mutations in chromosomal genes or through acquisition of 
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naturally occurring resistance genes from other bacteria (Schwarz et al., 2001; 
Alekshun & Levy, 2007; Sykes, 2010). Horizontal transfer of genes can occur 
within a bacterial species or over species boundaries either by uptake of naked 
DNA or through the integration of DNA in plasmids, bacteriophages, 
transposons, or other mobile genetic elements (Alekshun & Levy, 2007; Sykes, 
2010). Many resistance genes are clustered together on mobile genetic 
elements, meaning that a single transfer can result in the acquisition of 
resistance to multiple antimicrobials (Guardabassi & Kruse, 2008).  
The use of antimicrobials creates optimal conditions for resistance to 
emerge (Guardabassi & Kruse, 2008). Exposure to antimicrobials allows AMR 
strains to multiply in the absence of susceptible competitors (Schwarz et al., 
2001). Exposure to some bactericidal antimicrobials, such as betalactams, 
fluoroquinolones, and aminoglycosides, may also stimulate bacteria to produce 
reactive oxygen species (Kohanski et al., 2007). Reactive oxygen species may 
damage bacterial DNA, which results in the accumulation of mutations 
(Kohanski et al., 2010). Thus, exposure to low concentrations of bactericidal 
antimicrobials results in formation of multidrug-resistant mutants (Kohanski et 
al., 2010). Exposure to betalactam antimicrobials (Miller et al., 2004) or 
reactive oxygen species (Carlsson & Carpenter, 1980) may also activate the 
SOS-response. The SOS-response is evoked by DNA-damage which arrests 
cell division and induces mutagenesis and DNA repair (Janion, 2008). This 
response also promotes the transfer of resistance genes by increasing the 
expression of genes needed for gene transfer (Beaber et al., 2004).  
Exposure to one antimicrobial may select for resistance to other 
antimicrobials, because of cross- or co-resistance. Cross-resistance refers to 
single resistance genes or mutations conferring resistance to more than one 
antimicrobial class (Schwarz et al., 2001; Guardabassi & Kruse, 2008). Co-
resistance is the co-existence of several genes conferring resistance to different 
antimicrobials (Schwarz et al., 2001; Guardabassi & Kruse, 2008).  
Spread 
Resistant bacteria or their genes do not respect ecological, phylogenetic or 
geographical borders and thus, the epidemiology of resistance must be seen 
from a holistic and global point of view (Guardabassi & Kruse, 2008). 
Antimicrobial resistance spreads through bacteria populations both vertically, 
when new generations inherit resistance determinants, and horizontally, when 
bacteria share or exchange resistance genes with other bacteria (Witte, 2004). 
Horizontal transfer of resistance genes can occur within and between bacterial 
species (Schwarz et al., 2001; Witte, 2004). Bacteria that have acquired 
resistance may then spread between hosts by skin to skin contact, via excreta or 
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saliva containing the resistant bacteria, or by exposure to contaminated food, 
feed, air, or water (Schwarz et al., 2001). Human or animal excreta that contain 
resistant bacteria may contaminate the environment directly, or via the 
application of sludge or manure/slurry on lands (Marshall et al., 2009; 
Wellington et al., 2013). Spread to humans and animals then occurs through 
contact with soil, irrigation of crops, water, or wildlife (Wellington et al., 
2013). Finally, the movement of animals, food, and humans is a factor in the 
global dissemination of antimicrobial resistance (Laxminarayan et al., 2013). 
When resistant bacteria have reached the new host, they can either colonize, 
infect, or reside only transiently (Schwarz et al., 2001). In the new host, the 
resistant bacteria can spread their resistance genes to other bacteria, and also 
acquire other resistance genes from them (Schwarz et al., 2001).  
Use of antimicrobials by some individuals may enhance the spread of 
resistant bacteria to other individuals sharing the same environment. First, 
antimicrobial treatment decreases the ratio of susceptible to resistant organisms 
in the bacteria population that may colonize other animals or humans (Lipsitch 
& Samore, 2002). Second, antimicrobial treatment reduces the competition 
from the residing microbiota in the treated individual, and thus, increases the 
treated individual's risk of being colonized with a resistant strain from the 
environment (Lipsitch & Samore, 2002). 
1.1.2 The role of commensal E. coli 
Commensalism is a relationship between two organisms in which one benefits 
from the other without affecting it (Hogan, 2012). Commensalism exists 
between bacteria and animal/human hosts in various sites of their bodies, e.g., 
the skin and the gastrointestinal (GI) tract (Andremont, 2003). Although 
commensal bacteria are per definition harmless to their host, under certain 
conditions or in certain individuals, they can become pathogenic (Lupp & 
Finlay, 2005; Marshall et al., 2009). The commensal microbiota are large 
populations of bacteria (Andremont, 2003; Marshall et al., 2009), that are often 
in transient, but intimate, contact with bacteria from outside the body 
(Courvalin, 2008). During antimicrobial therapy for an infectious agent, the 
commensals are also exposed to selective pressure from the antimicrobial 
(Andremont, 2003; Courvalin, 2008; Marshall et al., 2009). Given the versatile 
pool of bacteria and genes in the commensal microbiota, there are ample 
opportunities for antimicrobial resistance to emerge (Andremont, 2003; 
Courvalin, 2008), both through emergence and selection of resistant strains 
(Andremont, 2003) and by transfer of resistance genes from indigenous 
bacteria to bacteria from outside the host and vice versa (Courvalin, 2008). The 
general belief is that resistance first emerges in the commensal microbiota and 
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then spreads by horizontal transfer to pathogens (Andremont, 2003). Hence, 
the level of AMR in commensals is considered a good indicator of the selection 
pressure by antimicrobials, but it is also predictive of the emergence of 
resistance in pathogens (van den Bogaard & Stobberingh, 2000).  
The GI microbiota represents by far the largest commensal population in 
the body (Andremont, 2003). It is therefore an important reservoir for 
multidrug-resistant bacteria (van den Bogaard & Stobberingh, 2000; 
Wellington et al., 2013). E. coli is a species that normally colonizes the GI 
tract of warm-blooded animals and humans (Anderson et al., 2006). This 
species is also found among some cold-blooded animals and in the 
environment, such as sediments and water reservoirs (Anderson et al., 2006; 
Marshall et al., 2009).  Due to its ubiquity, its relevance to human medicine, 
and the ease with which it acquires conjugative plasmids, E. coli from animal 
faeces is often used in resistance monitoring programmes as an indicator for 
acquired resistance in Gram-negative bacteria (Swedres-Svarm 2013; EFSA, 
2014).  
1.1.3 Antimicrobials and resistance of special concern 
Fluoroquinolones are classified as critically important antimicrobials for 
humans (WHO, 2012b) and emerging resistance to them is therefore of utmost 
concern. Unfortunately, quinolone resistance emerges rapidly as a consequence 
of exposure to it. After the introduction of enrofloxacin as a therapeutic agent 
on a US dairy farm in 2008, quinolone resistant E. coli (QREC) from faeces of 
calves increased from 1.3% in 2006 to 47.9% in 2011 (Jones et al., 2013). Due 
to the importance of this antimicrobial class for human medicine, this thesis 
focuses especially on risk factors and spread of QREC.  
Quinolone antimicrobials inhibit the activity of the DNA gyrase and 
topoisomerase II and IV, enzymes that relax the supercoiling of bacterial DNA 
and complete cell division (Ruiz, 2003). Quinolone resistance can be due to 
chromosomal mutations, acquisition of plasmid-mediated genes, or decreased 
uptake of the antimicrobial (Ruiz, 2003). In E. coli, mutations occur in the 
gyrase (gyrA or gyrB) or topoisomerase genes (parC or parE) (Ruiz, 2003). 
Accumulation of mutations in these genes results in stepwise increases in the 
minimum inhibitory concentration (MIC) (Ruiz, 2003; Cavaco & Aarestrup, 
2009) and cross-resistance to all members of the quinolone class is common 
(Ruiz, 2003). Plasmid-mediated resistance is conferred by the qnr genes, which 
have a protective effect on DNA gyrase, or by the aac(6)Ib-cr gene, which 
modifies fluoroquinolones enzymatically (Robicsek et al., 2006). Plasmid-
mediated resistance is often expressed as low-level resistance to 
fluoroquinolones (Cavaco & Aarestrup, 2009). Resistance due to decreased 
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uptake occurs either by increased impermeability or by overexpression of 
efflux pumps (Ruiz, 2003). Decreased uptake may also be associated with 
decreased susceptibility to other antimicrobials (Ruiz, 2003).  
1.2 Antimicrobial resistant faecal E. coli from dairy calves  
1.2.1 Occurrence of AMR E. coli in faeces of dairy cattle 
Antimicrobial resistance in faecal E. coli is less common in cattle than in other 
food-producing animals (Jong et al., 2009; EFSA, 2014). In Sweden, AMR E. 
coli is rarely isolated from slaughtered cattle (Swedres-Svarm 2013). The vast 
majority of E. coli isolated from calves aged 6 to 11 months 2013 (92%) and 
mature cows 2006 (97%) were susceptible to all tested antimicrobials (Svarm 
2006; Swedres-Svarm 2013). The occurrence of resistance in faecal E. coli 
from cattle is however, age-dependent. Faecal E. coli from calves is 
significantly more resistant, and often multidrug-resistant, compared to that in 
older cattle (DeFrancesco et al., 2004; Khachatryan et al., 2004; Sato et al., 
2005; Dolejská et al., 2008; Berge et al., 2010; Yamamoto et al., 2013; EFSA, 
2014). Wierup (1975) observed that E. coli isolates from 5-day old calves were 
more resistant and carried more transferrable resistance than E. coli isolates 
from 30-day old calves. Moreover, resistant strains from the younger calves 
transferred significantly more en bloc resistance, i.e. resistance to multiple 
antimicrobials (Wierup, 1975).  
Calves and cows are often housed in proximity to each other, often looked 
after by the same personnel, and exposed to the same microorganisms. The 
high level of resistance in faecal E. coli from calves is therefore a peculiar 
phenomenon. The following text offers potential explanations. 
1.2.2 Factors affecting faecal AMR E. coli in preweaned dairy calves  
Factors that may have an impact on the occurrence of faecal AMR E. coli in 
calves can be related to the calf itself, to external influences such as the diet or 
exposure to antimicrobials, to characteristics of the farm, and to management- 
associated factors. 
Use of antimicrobials 
High levels of faecal AMR E. coli in calves may be due to frequent exposure to 
antimicrobials. Likewise, antimicrobial use has been associated with increased 
occurrence of resistance among faecal E. coli from calves (Berge et al., 2005a; 
b, 2006; Di Labio et al., 2007; Jones et al., 2013; Yamamoto et al., 2013; 
Pereira et al., 2014b).  Berge et al. (2005b, 2006) and Singer et al. (2008) 
observed that the effect of individual antimicrobial treatment was transient, 
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with resistance levels returning to pre-treatment levels already within a few 
weeks post-treatment. On the other hand, some of the studies showed an 
association between farm-level usage of antimicrobials and AMR E. coli in 
calves (Di Labio et al., 2007; Jones et al., 2013; Yamamoto et al., 2013). This 
means that frequent antimicrobial use by individual animals may maintain a 
high level of AMR bacteria in the farm environment (Berge et al., 2005a). 
These AMR bacteria could then colonize the GI tract of the calves. However, 
levels of resistance in E. coli from young individuals are often high even 
without previous exposure to antimicrobials (Khachatryan et al., 2004; Berge 
et al., 2005a; Karami et al., 2006; de Verdier et al., 2012). Hence, frequent 
usage of antimicrobials is an insufficient explanation as to why calves carry 
more AMR E. coli than older animals do. 
1.2.3 The age of the calf 
Independent of resistance phenotype, colonization with AMR E. coli occurs 
shortly after birth (Hinton et al., 1985a; b; Hoyle et al., 2004b; Donaldson et 
al., 2006), and reaches a maximum within a few weeks (Hinton et al., 1985b; 
Hoyle et al., 2004a; Berge et al., 2005a; Donaldson et al., 2006). Thereafter it 
decreases  with calf age to negligible levels at four to six months (ampicillin 
and non-specific resistance), four months (apramycin),  and two months 
(nalidixic acid and extended spectrum betalactamase; ESBL) (Hinton et al., 
1984, 1985b; Hoyle et al., 2004a; b; Watson et al., 2012; Brunton et al., 2014). 
Hinton et al. (1985b) suggested that the age-related occurrence of resistance is 
due to the frequent turnover of E. coli strains in the developing gut of calves—
moving from mainly susceptible strains, to resistant ones, and then back to 
susceptible ones again. Susceptible E. coli serotypes from older calves were 
different from those isolated from the younger ones, indicating that the shift 
was due to acquisition of new susceptible strains rather than to re-
establishment of the same susceptible strains (Hinton et al., 1985a; b).  
Khachatryan et al. (2004) observed that resistant strains outcompeted 
susceptible strains in calves but not in older cattle. However, the resistance 
genes were not by themselves associated with the higher fitness of AMR E. 
coli in the calves' GI tract (Khachatryan et al., 2006b). Berge et al. (2005a) and 
Khachatryan et al. (2006b) suggested therefore that resistance is linked to traits 
that increase the colonization capacity in the young calf’s GI tract. Such traits 
could be the production of virulence or adhesion factors that promote 
colonization in the gut (Karami et al., 2006). 
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Diet factors 
A factor in common for most of the calf studies is that resistance is highest in 
the milk-feeding period (Hinton et al., 1984; Hoyle et al., 2004a; b; 
Khachatryan et al., 2004; Edrington et al., 2012b; Watson et al., 2012). 
Therefore, the milk diet has been proposed to be a risk factor. Given that 
ingestion of milk by itself would create optimal conditions for resistant strains 
in the calf gut, resistance levels should drop after weaning, but this was not the 
case in the studies of Edrington et al. (2012b) and Hinton et al. (1984). 
Likewise, AMR and susceptible E. coli grow equally well on agar plates 
supplemented with milk powder, indicating that milk by itself does not favour 
AMR strains over susceptible strains (Khachatryan et al., 2006a).  
If milk instead were a vehicle for the transfer of AMR bacteria to calves, 
pasteurizing the milk before feeding would decrease colonization with resistant 
strains. However, feeding pasteurized milk did not result in fewer faecal AMR 
E. coli (Aust et al., 2012; Edrington et al., 2012b).  
Supplementation of calf milk with antimicrobials is, in some countries, a 
common practice for disease prevention and growth promotion. This practice 
increased faecal AMR E. coli in the studies by Pereira et al. (2011) and Berge 
et al. (2006), but not in the study by Khachatryan et al. (2006a). However, 
Khachatryan et al. (2006a) added only a tetracycline component to the milk 
whereas Pereira et al. (2011) and Berge et al. (2006) added both tetracycline 
and sulfamethazine or neomycin. Thus, the lack of an effect from the 
tetracycline in Khachatryan et al. (2006a) may have been due to chelation of 
the antimicrobial by calcium and magnesium ions in the milk.  
Antimicrobials in milk fed to calves may also come from cows treated with 
antimicrobials. When a cow is given antimicrobials, the antimicrobial itself or 
degradation products thereof are usually excreted in the milk (Langford et al., 
2003; Randall et al., 2013; Pereira et al., 2014a). Colostrum or milk from cows 
treated with antimicrobials (here defined as waste colostrum; WC and waste 
milk; WM) may not be sold for human consumption and must be disposed 
elsewhere. One way of using WC and WM is to feed it to calves, which is a 
cost-effective solution for the farmer. Likewise, surveyed farmers in the UK 
stated that saving money was the major reason for feeding WM to calves, 
followed by avoiding problems with the disposal (Brunton et al., 2012). 
Although WC and WM can be of good nutritional quality, if they contain 
antimicrobials, this may put a selection pressure on the calves’ GI microbiota, 
possibly favouring resistant bacteria. This was investigated already in 1980 by 
Yndestad et al. (1980) and although they did not find a higher prevalence of 
faecal AMR E. coli among calves that were exposed repeatedly to 
antimicrobial-containing milk, their study material was small. Ten years later, 
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Wray et al. (1990), observed that the faecal E. coli from calves given WM had 
significantly higher MIC for streptomycin, but not for ampicillin than E. coli 
from calves fed milk substitute. Langford et al. (2003) revealed a dose-related 
relationship between the penicillin concentration in milk and the degree of 
penicillin inhibition of unspecific bacteria from calves fed such milk. However, 
the results of that study must be interpreted cautiously due to the inaccuracy of 
the methods used. Researchers in Denmark did not find a difference in 
resistance levels of faecal E. coli on farms that gave milk from antimicrobial-
treated cows to calves compared to farms that did not (Sörensen et al., 2008), 
but again, the study material was small. Finally, Würgler-Aebi (2004) advised 
against the feeding of milk from cows treated with antimicrobials after 
observing that the relative number of AMR Enterococci increased markedly in 
calves fed such milk. Taken together, these results are inconclusive and thus, 
more and better studies are needed. Moreover, to our knowledge, no one has 
investigated the importance of feeding colostrum from cows treated with dry-
cow antimicrobials. It is therefore uncertain to what extent feeding WC selects 
for AMR E. coli in the GI tracts of calves. 
Other factors 
Many other factors affect the carriage of faecal AMR E. coli in calves, such as 
the incidence of diarrhoea (Gunn et al., 2003; de Verdier et al., 2012), herd 
size (de Verdier et al., 2012), farm type (beef, calf ranch, or dairy) (Berge et 
al., 2010), production type (organic or non-organic) (Sato et al., 2005), 
infrequent disinfection of calf feeding equipment, storage of slurry in a pit, 
keeping purchased cattle in quarantine (Snow et al., 2012), purchase of calves 
(particularly from several suppliers) (Di Labio et al., 2007), and vitamin 
supplements (Khachatryan et al., 2006a). There may also be other, yet 
unidentified factors. 
1.3 Dissemination of AMR E. coli on dairy farms 
When studying factors that affect the occurrence of faecal AMR E. coli in 
calves, it is crucial to investigate the spread of AMR E. coli between calves, in 
other cattle, and in the farm environment.—these may be potential sources and 
dissemination routes. However, one of the major problems when studying the 
epidemiology of antimicrobial resistance is that different resistance traits may 
behave in different ways. What complicates the picture is that spread by clonal 
dissemination, horizontal plasmid transfer, horizontal transfer of genes, or a 
combination of these events may occur (Liebana et al., 2006). Overall, little is 
known about the spread of AMR E. coli within and between dairy farms.  
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Watson et al. (2012) made a longitudinal analysis of the epidemiology of 
ESBL-resistance in E. coli on a dairy farm in the UK. In that study, ESBL-
producing E. coli was found in calf faecal samples and persistently in water 
troughs in the calving pen, but only occasionally in those in the dry cow pen. 
Moreover, such strains were persistently recovered from pen walls in the 
calving- and calf pens. Cows were also more likely to shed ESBL-producing E. 
coli after compared to before calving. These authors therefore suggested that 
transition via the calving area may be a crucial pathway for the dissemination 
of ESBL-producing E. coli between different cattle categories (Watson et al., 
2012). These results indicate that ESBL resistance disseminates within the 
farm via both clonal spread and via transfer of genes on conjugative plasmids 
(Watson et al., 2012), similar to the earlier study by Liebana et al. (2006). 
Liebana et al. (2006) also showed that the same ESBL-producing E. coli clone 
persisted on the farm over time.  
Since horizontal transfer of genes conferring quinolone resistance is still a 
rare event in E. coli from cattle (Jurado et al., 2008; Kirchner et al., 2011; 
Hordijk et al., 2012; Marchese et al., 2012), quinolone resistance is assumed to 
spread mainly by clonal expansion. Likewise, the same clone of QREC 
disseminated throughout the herd in Hoyle et al. (2005). Clonal spread of 
faecal AMR E. coli between different age categories was also observed on 
dairy farms in Japan (Yamamoto et al., 2013).  
It has been suggested that young animals are colonized with AMR E. coli 
from faeces of their mothers at birth (Bettelheim et al., 1974; Watson et al., 
2012; Callens et al., 2014). However, neither Gow et al. (2008) nor Watson et 
al. (2012) could find evidence that the mother’s faecal microbiota was the only 
source of AMR E. coli. Instead, the farm environment may be a more 
important source for colonizing strains, as suggested by Hinton et al. (1985b) 
and Yamamoto et al. (2013).  
More knowledge about the dissemination of AMR E. coli within and 
between farms and related risk factors is needed before making best-practice 
recommendations to reduce the dissemination of AMR E. coli.  
1.4 Zoonotic aspects 
A zoonosis is defined by WHO as any infection that is naturally transmissible 
between vertebrate animals and humans (WHO, 2015) and resistant bacteria is 
thus also covered by this definition. The interface between human and animals 
is complex; numerous pathways exist for the spread of AMR bacteria. Van den 
Bogaard et al. (2001) suggest that AMR E. coli reaches humans by direct 
contact or via contaminated food. Resistant E. coli from cattle may 
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contaminate milk (Straley et al., 2006) and meat products (Alexander et al., 
2010) and subsequently spread to humans via the food-chain. Normally, proper 
cooking and pasteurization is sufficient to inactivate bacteria in meat and milk 
(Alexander et al., 2010). However, improper handling of the faeces-
contaminated food may pose a risk for humans to be colonized with AMR E. 
coli from food (Alexander et al., 2010). Corpet (1988) showed that the amount 
of contamination with AMR bacteria on food was correlated to the levels of 
AMR bacteria in the faecal microbiota of humans ingesting the food. Smith 
(1969) observed that E. coli of animal origin persisted poorly in the GI tract of 
humans, whereas both Linton et al. (1977) and Trobos et al. (2009) came to the 
opposite conclusion. Although E. coli in itself may cause infections in humans, 
the zoonotic potential of AMR E. coli in the food-chain comes mainly from the 
transfer of resistance genes from animal origin commensals to human 
pathogenic bacteria (van den Bogaard & Stobberingh, 2000). Although 
colonisation of the human gut by animal-derived strains is occasionally 
transient, there may be sufficient time for the transfer of resistance genes 
(Trobos et al., 2009). Levy et al. (1976) observed that tetracycline resistance 
genes could be transferred between chicken and human E. coli. Winokur et al. 
(2001) showed that an AmpC-type betalactamase gene was transmitted from 
animal E. coli to human pathogenic Salmonella.  
1.5 The current dairy cow sector in Sweden 
Sweden currently has 344,000 dairy cattle, distributed on 4,400 farms with an 
average herd size of 78.4 cows (Swedish Board of Agriculture, 2014). Eighty-
four percent of Swedish dairy cows are enrolled in the Swedish Official Milk 
Recording Scheme (SOMRS) (Växa Sverige, 2014). The average milk 
production for cows enrolled in SOMRS is 9,535 kg energy-corrected milk and 
the average geometric somatic cell count is 192,000 cells per mL of delivered 
bulk milk (Växa Sverige, 2014). Since 1990, the number of farms has 
decreased by 70%, the herd size has increased by 178%, and the milk yield has 
increased by 30% (Swedish Board of Agriculture, 2014). Hence, the Swedish 
dairy sector has undergone dramatic changes over a short period. In 2013, 
approximately 13% of all milk produced was certified by one or another 
organisation for organic farming (Swedish Board of Agriculture, 2014). 
Swedish cows are housed in either insulated or cold barns, a majority of them 
in free stall housing (60%)1 for most of the year. In contrast to other countries, 
all Swedish cows must be released on pasture for stipulated periods each year.  
                                                        
1. Eva Stormwall, Växa Sverige, personal communication 
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Dairy farming in Sweden is strictly regulated under the Animal Welfare 
Act2 and the Animal Protection Ordinance3. Sweden also has a long tradition of 
preventive health measures; these have been successful in the eradication of 
bovine viral diarrhoea, brucellosis, infectious bovine rhinotracheitis, 
tuberculosis, and bovine enzootic leucosis (Anonymous, 2013). Sweden is also 
presently considered free from paratuberculosis (Anonymous, 2013). Control 
programmes have been initiated for diseases such as Salmonella; the incidence 
in slaughtered Swedish cattle is therefore low  (Anonymous, 2013). Consistent 
work with preventive measures has led to a low disease incidence among 
Swedish dairy cows (Växa Sverige, 2015) which minimizes the need for 
antimicrobials. 
1.5.1 Usage of and prescription of antimicrobials  
In Sweden, usage of antimicrobials in dairy cattle requires a prescription and 
such drugs cannot be dispensed without veterinary examination of the animal 
(Swedish Board of Agriculture, 2013). Moreover, veterinarians are not allowed 
to make profit by selling drugs (Veterinärutredningen, 2007). Follow-up 
treatment of the same animal or a group of animals can be administered by the 
farmer for a limited time (Swedish Board of Agriculture, 2013). As of 2016, 
conditional delegated treatment (Villkorad läkemedelsanvändning) may 
become a possibility on dairy farms. This means that farmers are allowed to 
diagnose and treat certain conditions on their own, given close collaboration 
with a herd-veterinarian (including regular visits). For the farmer, this requires 
strict recording of disease events and treatments as well as the completion of a 
course on legal requirements, risks associated with antimicrobials including 
resistance, handling and storage of medicines, injection techniques and safety 
aspects. The aim is to promote preventive measures to increase animal health 
and welfare (Swedish Board of Agriculture, 2013).  
Antimicrobials for growth promotion were banned in 1986 (as the first 
country ever) (Cogliani et al., 2011) and the use of antimicrobials for 
prophylaxis is not recommended. For domestic animals in Sweden, 90% of the 
antimicrobials consumed are for treatment of individual animals and only 10% 
for treatment of flocks or groups (Swedres-Svarm 2013). This is in contrast to 
many other European countries (ESVAC 2012). Furthermore—unlike in other 
European countries—few drug classes are used and the by far most sold drug is 
betalactamase-sensitive penicillin (ESVAC 2012). Recently, the veterinarian’s 
right to prescribe fluoroquinolones and third and fourth generation 
cephalosporins is restricted to situations where culture and susceptibility 
                                                        
2. SFS no: 2003:1077, issued by the Ministry for Rural Affairs 
3. SFS no: 1988:539, issued by the Ministry for Rural Affairs 
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testing have proven that no other available antimicrobial is expected to be 
effective. However, acute, life-threatening cases do not have to await 
culturing/susceptibility testing results. Moreover, fluoroquinolones can be 
prescribed in cases where culturing and susceptibility testing of the same 
infectious agent in the previous six months showed that no effective 
alternatives were available (Swedish Board of Agriculture, 2013). 
Benzylpenicillin is the drug of choice against many bacterial infections in 
dairy cattle (Sveriges Veterinärmedicinska Sällskap, 2013). It is by far the most 
commonly prescribed antimicrobial (84% of total amount prescribed to cows in 
SOMRS), followed by tetracycline (7%), trimethoprim-sulfonamides (5%), 
enrofloxacin (3%), and ceftiofur (0.5%). The majority of systemic 
antimicrobials used in dairy cattle in SOMRS are prescribed for clinical 
mastitis (69%) (Växa Sverige, 2015). These are most often administered 
systemically; only a few veterinarians use the local route (Hårdemark, 2014). 
In contrast to many other countries, selective and not blanket dry cow therapy 
(DCT) is applied, meaning that antimicrobial treatment at drying off is used 
only for selected cows. Therefore, only approximately 26% of Swedish dairy 
cows were treated at drying off in 2013 (Swedres-Svarm 2013).  
Data on the use of antimicrobials for calves is scarce due to incomplete 
registration in the National Animal Disease Recording Scheme (NADRS) 
(Mörk et al., 2009). Treatment statistics are therefore limited to single surveys. 
Ortman & Svensson (2004) observed that 669 of the 3081 dairy heifers from 
birth to 90 days acquired an infectious disease. Of those, 38% were treated 
with antimicrobials (Ortman & Svensson, 2004). Respiratory illness and 
diarrhoea were the most common causes for treatment (Ortman & Svensson, 
2004). In more than half of the cases, the drug was administered without 
consulting a veterinarian, probably with left-over drugs from a previous 
veterinary prescription. Despite recommendations, broad-spectrum 
antimicrobials were often used (Ortman & Svensson, 2004). For calves 
between birth and 90 days, the most commonly used drug and administration 
route was systemic penicillin in combination with dihydrostreptomycin (DHS; 
55% of total amounts used), followed by systemic procaine penicillin (14%), 
DHS tablets for per oral administration (11%), systemic tetracycline (10%), 
and systemic trimethoprim-sulfonamide combinations (6%) (Ortman & 
Svensson, 2004). Benzylpenicillin is the drug of choice for most calf diseases 
requiring antimicrobials, except for severe diarrhoea or septicaemia for which 
trimethoprim-sulfonamide is a more appropriate alternative (Sveriges 
Veterinärmedicinska Sällskap, 2013). 
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1.5.2 Feeding milk to calves from cows treated with antimicrobials 
Milk from cows treated with antimicrobials may not be sold for human 
consumption until stipulated time periods have elapsed since the last 
administration (withdrawal period). In Sweden, these withdrawal periods are 
determined by the Medical Products Agency as the time periods required for 
drugs in milk to decrease to below their maximum residue limit (Medical 
Products Agency, 2014). The withdrawal period is typically between zero and 
twelve days, depending on the antimicrobial, and up to fourteen days for some 
trimethoprim-sulfonamide combinations when administered twice daily (FASS 
Vet, 2015). There are two licensed, long-acting products for dry cow treatment. 
For one of them, the milk must be withheld for four days after calving if used 
at the latest one month before calving. If the administration was less than 30 
days before calving, the withdrawal period has to be extended substantially. 
For the other product, milk may not be sent to the dairy plant for 36 hours after 
calving if it was administered at latest 35 days prior to calving. If administered 
later than 35 days before calving, the total withdrawal period is 37 days from 
the treatment day (FASS vet, 2015). On organic farms, withdrawal periods are 
in general the double and two days if the statutory period is zero days (KRAV, 
2015). 
Instead of discarding withdrawn milk, it is sometimes fed to calves. It is 
likely that Swedish dairy calves are fed milk from cows treated with 
antimicrobials, but to what extent is unknown. Healthy animals should not be 
exposed to antimicrobials, and the feeding of such milk may therefore be 
controversial from a resistance point-of-view. For non-organic farms, there are 
no formal regulations because the Animal–By-Products regulation4 does not 
cover animal waste disposed on the farm. The disposal of such milk is 
probably done according to the farmer’s own experiences and traditions.  
Feeding milk from antimicrobial-treated cows is prohibited on organic 
farms during the statutory withdrawal period, except to the cow’s own 
offspring (KRAV, 2015). Växa Sverige (one of three livestock associations in 
Sweden) has issued some recommendations related to the use of such milk as 
calf feed, but these are not scientifically based. They recommend that milk 
from cows treated with antimicrobials during lactation should be discarded 
until the second day after treatment and for colostrum from cows given DCT, 
from the third complete milking after calving5. However, it is unknown to what 
extent these recommendations are followed in the field.  
As stated previously, there are unique prerequisites in Sweden for use of 
antimicrobials. The majority of discarded milk from antimicrobial-treated cows 
                                                        
4. Animal-by-products regulation (EC) No 1069/2009 issued by the European Union 
5. Håkan Landin, Växa Sverige, personal communication 
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comes from cows treated systemically with benzylpenicillin. Since E. coli is 
intrinsically resistant to that drug (Giguré et al., 2006), feeding milk with 
penicillin residues is not assumed to have an effect on the AMR levels in faecal 
E. coli from calves, but studies are still needed to confirm or dismiss such an 
assumption.  
  
26 
 
 
 
27 
2 Aims of the thesis 
The overall aim of the thesis was to obtain knowledge about the prevalence, 
risk factors, and spread of faecal AMR E. coli in preweaned dairy calves. This 
information will be used to define measures to reduce the overall burden of 
AMR E. coli on dairy farms. Specific objectives were to describe:  
 
 The occurrence of AMR E. coli (with special focus on QREC) in relation 
to calf and farm characteristics, use of antimicrobials on the farm, feeding 
milk from antimicrobial-treated cows to calves, management factors and 
biosecurity factors. 
 
 Practices regarding the feeding of colostrum and milk from cows given 
antimicrobials to calves in relation to different farm characteristics. 
 
 The within-farm occurrence of QREC on dairy farms in relation to the 
prevalence of QREC in calves to identify potential dissemination routes 
for these bacteria. 
 
 The genetic diversity of QREC within and between dairy farms and relate 
it to risk factors for the spread of QREC.  
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3 Materials and Methods 
This section gives an overview over the materials and methods that forms the 
basis of the studies in this thesis. Detailed information is given in papers I-IV. 
3.1 Summary of the study designs 
 Paper I was a questionnaire survey investigating management routines 
related to the feeding of colostrum and milk from cows treated with 
antimicrobials to calves. 
 Paper II was a cross-sectional study for risk factors related to the shedding 
of AMR E. coli by preweaned dairy calves. 
 Paper III was a case-control study, investigating risk factors related to the 
shedding of QREC by preweaned dairy calves and post-partum dairy cows. 
 Paper IV was a case-control study on the occurrence and genetic diversity 
of QREC on dairy farms.  
3.2 Study populations 
The study populations in papers I-IV were all derived from a group of farmers 
that took part in the questionnaire survey in paper I. Figure 1 summarizes the 
selection process of study farms.  
The study population in paper I was recruited using a list of farms with e-
mail addresses obtained from Växa Sverige. The use of a web-based survey 
tool limited the study population to farms that could be contacted 
electronically. The group of farms responding to the questionnaire was a 
representative sample of the general dairy-farm population with regard to 
geographic location and herd size.  
The study population in paper II was recruited via the questionnaire in 
paper I. As a final question, respondents were asked to take part in the study in 
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paper II which involved submission of faecal samples from calves. Of those 
that voluntarily signed up for the study in paper II, only farms with ≥ 30 cows 
were enrolled. The farms enrolled were also representative of Swedish dairy 
farms with ≥ 30 cows regarding geographic location and herd size. 
All Swedish dairy farms 
with e-mail adresses 
registered in SOMRS*
Took part in the questionnaire 
survey (n =457 farms)
Paper I
Voluntarily agreed to contribute 
with faecal samples from 
preweaned dairy calves
Herd size ≥ 30 cows 
(n = 243 farms)
Paper II
Used quinolones, insulated 
free stall barns, located in 
southern or eastern Sweden
Farms with varying mean within-sample prevalence 
of quinolone resistant Escherichia coli (n = 23)
Papers III and IV
Did not use quinolones, cold 
free-stall barns or tie-stall 
barns, located in northern 
Sweden
Herd size < 30 cows
Did not take part in the 
questionnare survey
Figure 1. A flow-diagram of the selection process of farms enrolled in the studies in papers I-IV. 
*SOMRS is the Swedish Official Milk Recording Scheme 
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In papers III and IV, the study population consisted of 23 farms from the 
study in paper II, all which used fluoroquinolones, had insulated free-stall 
barns and were located in southern or eastern Sweden, but differed regarding 
their prevalence of QREC in faecal samples from calves. The farms were 
selected based on the mean within-sample prevalence of faecal QREC for three 
calves per farm (paper II). Potential case farms had a mean within-prevalence 
of QREC > 10% (n = 14 farms) and potential control farms had no QREC (n = 
20 farms). Case farms were asked in a descending order of prevalence to take 
part in the study, and a total of ten farms were recruited. A total of eleven 
control farms were, in a random order, asked to participate, before ten farms 
could be enrolled. Finally, three farms with moderate mean within-sample 
prevalence of QREC (0.02 - 0.8%) were enrolled. These three farms did neither 
meet the criteria for cases nor controls, but were selected due to the presence of 
E. coli carrying genes encoding ESBL which were of interest for a parallel 
study where the shedding of E. coli resistant to third generations’ 
cephalosporins was studied. 
3.3 Sampling procedures 
In papers II-IV, different types of samples were collected to investigate the 
occurrence of AMR E. coli in faecal, environmental and milk samples. The 
same faecal samples from cows and calves were used in papers III and IV. 
3.3.1 Faecal samples 
In papers II-IV, faecal samples from individual animals were collected by 
rectal swabs using Amie’s charcoal culture swabs (Copan Diagnostics Inc., 
Murrieta, California, USA). The faecal samples in paper II were from three 
calves (7 to 28 days old) per farm, collected by the farmers and sent by postal 
transport to the National Veterinary Institute (SVA). The faecal samples in 
papers III and IV were from 15 calves (0 to 30 days), and five cows (0 to 3 
days post-partum). Samples in papers III and IV were collected by the author 
of the thesis with some additional sampling by the farmers and sent by post or 
brought by car to the laboratory.  
3.3.2 Environmental samples 
The environments within the dairy farms in paper IV were sampled using a 
commercial kit called “Sterile cloth” (Sodibox, Névez, France). This product 
was developed for surface sampling on farms and food industries for 
monitoring of Salmonella and other bacteria. The cloths were used to sample 
calf feed troughs, calf water troughs, milk buckets, automatic milk feeders, and 
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walls in calf pens and the calving area. Up to three samples per sampling site 
were collected. 
Overshoe sampling (Aho, 1992) was conducted to obtain pen floor samples 
from all cattle categories on the farms (except calves below 30 days) (paper 
IV). For this purpose, another commercial kit called “Sterisocks humid” 
(Sodibox) was used. Samples were collected from the floors in the lactating 
cow area, dry cow area, calving area, and in pens with young stock aged 1 to 6 
months, and 7 to 24 months. Up to three samples per sampling site were 
collected. After collection, all samples were sent by post or brought by car to 
the laboratory.  
3.3.3 Milk samples 
In paper IV, five milk/milk substitute and five colostrum samples were 
collected in sterile plastic tubes by each farmer. The milk, milk substitute, or 
colostrum designated as calf feed was sampled just before feeding by dipping 
the plastic tube into the milk in the feeding equipment using a gloved hand. All 
milk samples were sent by post at ambient temperature (Nov – Feb) to the 
laboratory and stored frozen until analysis.   
3.3.4 Determination of farm hygiene 
While sampling for papers III and IV, the general hygiene of the farms was 
determined as the degree of faecal contamination in all environmental 
sampling sites described above. The hygiene was scored by the primary 
investigator (AD) on user-defined scales (0 to 3), where 0 was defined as clean 
surfaces and 3 as heavily faeces-contaminated areas.  
3.4 Antimicrobial susceptibility testing 
3.4.1 Preparation of samples 
Rectal swabs were transferred to tubes with isotonic saline, 1 mL in paper II 
and 3 mL in papers III-IV, and vortex mixed to release faecal content. Isotonic 
saline, in aliquots of 100 mL, was added to the environmental samples (socks 
and cloths) before they were treated in a stomacher for 30 seconds. 
Environmental samples from the same sampling site within each farm were 
pooled by mixing aliquots (2 mL) of each sample suspension. Tenfold dilutions 
down to 10-5 (paper II), or 10-6 (papers III and IV) were prepared from the 
mixed suspension using isotonic saline.  
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3.4.2 Selective media 
In papers II-IV, the proportion of resistant E. coli to total E. coli in each sample 
(within-sample prevalence) was determined for all sample suspensions by 
parallel plating on selective and non-selective media.  
In paper II, samples were plated and E. coli counted on non-supplemented 
MacConkey agar plates and MacConkey agar plates supplemented with either 
streptomycin (32 mg/L), nalidixic acid (32 mg/L), or cefotaxime (1 mg/L).  
In papers III and IV, sample suspensions were cultured and E. coli counted 
on Petrifilm Select E. coli Count Plate (SEC plate; 3M Microbiology Products, 
St. Paul., MN, USA). Sample suspensions were cultured on SEC plates directly 
and after addition of a nalidixic acid solution. The final concentration of 
nalidixic acid on the SEC plate was 32 mg/L. 
3.4.3 Broth microdilution  
In paper II, the MIC (for each of 12 antimicrobials) of a random E. coli from 
the non-supplemented MacConkey (confirmed as E. coli using the spot indole 
test) was determined using broth microdilution according to the CLSI (2013) 
standards. Tests were performed in VetMIC GN-mo panels (ver. 4, National 
Veterinary Institute, Uppsala, Sweden).  
3.5 Molecular typing methods 
3.5.1 Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) was used in paper II to investigate the 
presence of genes encoding transferrable ESBL or plasmid-mediated AmpC 
betalactamases (pAmpC). For this purpose, all cefotaxime resistant (Ctxr) 
isolates confirmed as E. coli (using the spot indole test) were screened by two 
multiplex-PCRs for detection of the following phylogenetic gene groups: 
pAmpC (Pérez-Pérez & Hanson, 2002) and blaCTX-M (Woodford et al., 2006), 
respectively.  
PCR was also used in paper IV for preparation of amplicons for Multiple 
Locus Variable-number Tandem Repeat Analysis (MLVA), see details in 3.5.2. 
In the MLVA-assay, ten loci were amplified in four multiplex-PCRs and one 
singleplex-PCR (Lindstedt et al., 2007; Løbersli et al., 2012). The protocol was 
modified according to Lindstedt et al. (2007) and Løbersli et al. (2012). 
3.5.2 Multiple-Locus Variable-number tandem repeat Analysis  
In paper IV, MLVA was used to determine the genetic relatedness of QREC. 
Preparation of amplicons is described under section 3.5.1. In the final step of 
the MLVA-assay, the length of PCR amplicons (the number of tandem repeats 
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in each of ten loci) was determined by capillary electrophoresis. On the basis 
of the number of repeats, each locus was designated an allele number, resulting 
in a unique MLVA allelic profile for each strain.  
3.5.3 Sequencing of specific variants of ESBL and pAmpC genes 
For genes encoding ESBL or pAmpC found in the studies in paper II, the 
specific gene variants of the phylogenetic groups identified by PCR were 
determined by sequencing, using group-specific primer-pairs according to 
Sundsfjord et al. (2004). 
3.6 Data from questionnaires and interviews 
A major part of the data used to test the effect of various factors on resistance 
in faecal E. coli form calves was obtained from the farmers via questionnaires.  
3.6.1 Paper I 
Paper I was based mainly on questionnaire data regarding farm practices 
related to the feeding of calves with waste colostrum (WC: from the first 
milking after calving), waste transition milk (WT: from the second milking 
until the fourth day after calving) and waste milk (WM) from cows treated with 
antimicrobials during lactation (during ongoing treatment; TWM and during 
the statutory withdrawal period; WWM). The questionnaire was developed by 
the author in the online survey platform Easyresearch6 and a survey URL link 
was made available to farmers via e-mails, on Växa Sverige’s webpage, and in 
farmer-managed groups in social media. The questionnaire was developed with 
conditional branching, which directed questions only to those respondents that 
they were applicable for.  
3.6.2 Paper II 
Data on the use of colostrum and milk from cows treated with antimicrobials 
from the survey in paper I was used in the risk factor analysis for AMR in 
faecal E. coli from calves (paper II). A second web-based survey was sent by 
e-mail to farms (paper II) to obtain data on use of antimicrobials to cows and 
preweaned dairy calves. The questions were designed to obtain a semi-
quantitative estimate of the frequency of antimicrobial treatments; more 
precisely as how often antimicrobials were used in a defined time interval 
(year, month, or week). Semi-quantitative responses were transformed to 
quantitative estimates, using the “best-guess” interpretation of the number of 
                                                        
6 www.easyresearch.se 
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antimicrobial treatments included in each response option and adjusted for herd 
size to allow between-herd comparisons. 
3.6.3 Paper III 
In paper III, data on biosecurity factors, management and feeding of calves, 
and routines around calving were obtained through a structured (face-to-face) 
interview with the farmer during the farm visits. Data on recent use of 
antimicrobial drugs (last four months) were obtained from on-farm records and 
veterinary invoices.  
3.7 Data from other sources 
In paper I, data on herd size, geographic location (postal codes), and 
predominant milking and housing system were retrieved from the SOMRS. In 
paper II, data on prescription of antimicrobials on each farms from NADRS, 
data on predominant breed, mean herd-size, and geographic location were 
obtained from the SOMRS database. In paper IV, data on animal trade patterns 
were obtained from the central register of bovine animals (Swedish Board of 
Agriculture, Jönköping, Sweden), whereas data on distances between farm-
pairs were recorded by manually measuring distances on the map in Google 
maps (https://maps.google.com) using the “distance measuring” application. 
3.8 Statistical analysis 
Statistical analyses were used in all four papers to investigate significant 
differences between groups of farms or to assess the association between 
various factors on the occurrence of AMR E. coli.  
In paper IV, farms were categorised as high (H) and low (L) farms, based 
on the mean within-sample prevalence of QREC in faeces from preweaned 
calves (H ≥ 0.5% > L). 
Fisher’s exact test was used to investigate the association between farm 
characteristics and management routines (paper I), and to compare the 
occurrence of QREC in different age categories or samples (paper IV), 
between farms where QREC was common in faeces from calves (H-farms) and 
farms where QREC was rare (L-farms) in calves (paper IV). Moreover, this 
test was used to assess the representativeness (geography) of studied farms in 
papers I and II compared with the general population of dairy farms in Sweden. 
The Wilcoxon signed rank test was used to assess the representativeness of 
farms (herd size, papers I and II), and to investigate significant differences in 
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the within-sample prevalence of QREC in various samples and on H- and L-
farms (paper IV).  
Analysis of correlation, using the Spearman rank-order correlation 
coefficient, was used in paper IV to investigate significant associations 
between the genetic diversity of QREC and the number of purchased cattle. A 
two sided t-test was used to compare the between-farm distance for farm-pairs 
with and without at least one shared MLVA type. 
Multivariable regression analyses was conducted in papers II and III to 
investigate the importance of various risk factors for the occurrence of AMR E. 
coli. If the outcome was the proportion of animals shedding resistant E. coli, 
logistic regression was used. If the outcome variable was the within-sample 
prevalence of resistant E. coli, zero-inflated negative binomial regression was 
used. The individual animal (cow or calf) was the study unit and clustering 
within a farm was accounted for using robust standard errors. Potential risk 
factors were first tested in univariable analyses. All variables (given no 
collinearity) in paper III, and variables with p ≤ 0.2 in paper II, were eligible 
for the multivariable analyses. In paper II, a manual stepwise-backwards 
elimination was applied, whereas in paper III, a manual stepwise-forwards 
selection procedure was used.  
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4 Results 
A summary of the results presented in papers I to IV is given below. For a 
more detailed description of the studies, the reader is referred to each paper. 
4.1 Prevalence of AMR E. coli  
4.1.1 Selective plates 
Streptomycin resistance (paper II) 
Streptomycin resistant (Smr) E. coli was isolated from 90% of the calves (aged 
7 to 28 days), representing 96% of the 243 farms. The within-sample 
prevalence of Smr E. coli for individual calves ranged from 0 to 100%, where 
the median, 25th, and 75th percentiles were 4, 0.07, and 32%, respectively.  
Quinolone resistance (papers II and III) 
In paper II, QREC was isolated from 49% of the calves (aged 7 to 28 days), 
representing 60% of the farms. The within-sample prevalence of QREC for 
individual calves ranged from 0 to 100% and the median, 25th, and 75th 
percentiles were 0, 0, and 0.5%, respectively. 
In paper III, QREC was found on 22 of the 23 farms. Quinolone resistant E. 
coli was isolated from calves (aged 0 to 30 days) on all but one farm and from 
post-partum cows on 13 of the 23 farms. Significantly more calves (60%) than 
cows (27%) carried QREC. Likewise, a significantly higher within-sample 
prevalence of QREC (median 0.0003%) was found in faeces from calves than 
cows (median 0%). 
Cefotaxime resistance and ESBL (paper II) 
Cefotaxime resistant E. coli was isolated from 11% of the 729 calves (aged 7 to 
28 day), representing 18% of the 243 farms. The within-sample prevalence of 
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Ctxr E. coli for individual calves ranged from 0 to 78%, and the median, 25th, 
and 75th percentiles were all 0%. 
Genes conferring ESBL or pAmpC-resistance were found in 9 of 81 tested 
isolates of Ctxr E. coli. Four of these isolates carried blaCTX-M-15, one carried 
blaCTX-M-1, and four carried blaCMY-2. The remaining 72 isolates did not carry 
any of these transferable genes. 
4.1.2 Resistance in randomly selected E. coli isolates (paper II) 
The proportion of the 729 E. coli isolates (one isolate each from calves aged 7 
to 28 days) resistant to each of 12 antimicrobials is described in Figure 2. 
Resistance to at least one antimicrobial was seen in 48% of the isolates, and 
multidrug resistance (resistance to three or more antimicrobials) was observed 
in 27% of the isolates. The most common multiresistant phenotype was the 
AMR combination Smr-Sulfamethoxazole (Sur)-Tetracycline (Tcr).  
4.2 Risk factors for AMR E. coli (paper II) 
Significant risk factors for the shedding of AMR E. coli were related to calf 
factors, farm characteristics and seasonal effects, farm-level antimicrobial 
usage, and farm-level use of WM as calf feed. A simplified summary of 
significant risk factors that affected the shedding of AMR E. coli in faeces of 
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Figure 2. The proportion of randomly selected E. coli isolates (n = 729) from preweaned dairy 
calves aged 7 to 28 days resistant to each tested antimicrobial (paper II). 
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preweaned calves is found in Table 1, followed by a more detailed explanation 
in later sections.  
Table 1. Summary of factors in paper II associated with the shedding of resistant E. coli in faeces 
of preweaned dairy calves. Lower occurrence of resistance is indicated by an arrow pointing 
down, and higher occurrence by an arrow pointing up. The symbol – indicates no significant 
association between a factor and resistance. 
Factor Selective plates  Random E. coli 
Ctx QREC1 Sm  Am Cm Ci Km Nal Sm Su Tc 
Ageing calf  - ↓ ↓  ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ 
Group vs. single calf housing2 ↑ - -  - - - - - - - ↓ 
Large vs. small herds ↑ ↑ ↑  - - ↑ ↑ ↑ ↑ - ↑ 
South/East3 vs. North Sweden - ↑ -  - ↓ - - - - - - 
Swedish Holstein vs. Swedish 
Red or mixed breed 
- ↑ -  - ↓ ↑ - ↑ - - - 
Tie stall /Automatic milking 
system vs. parlour milking 
- - -  ↓ - - - - - - ↓ 
Feeding waste milk to calves at 
least occasionally 
- ↑ ↑  - - - - ↑ ↑ - - 
Oct – Dec vs. Jan – Sep  - - ↓  - - - - - - - - 
Ceftiofur to cows - - -  ↑ - - - - - - - 
Ceftiofur to calves ↑ - -  - - - - - - - - 
Oral DHS4 calves - ↑ ↑  - - ↑ - ↑ ↑ - - 
Penicillin-DHS to calves - - ↑  - - - - - - - - 
More cows treated with long-
acting DCT5 
- - ↑  - - - - - - - - 
Short-acting DCT - - ↑  - - - - - - - - 
Fluoroquinolones to cows - ↑ -  - - - - - - - - 
Trimethoprim-Sulfonamide to 
calves 
- ↑ -  - - - - - - - - 
Tetracycline to cows - - -  - - ↑ - ↑ - - ↑ 
Tetracycline to calves - - -  - ↑ - - - - - ↑ 
1Quinolone resistant E. coli, 2For Tcr group housing with at least one calf > 30 days, 3For Cmr, South vs. 
North/East Sweden, 4Dihydrostreptomycin, 5Dry cow therapy with antimicrobials 
Calf factors  
Increasing calf age led to a decreased within-sample prevalence of Smr and 
QREC and to decreased odds of all resistance traits except Ctxr. The 
occurrence of AMR E. coli was at its maximum at one week of age and 
declined gradually thereafter.  
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Group housing of the calf led to higher odds of Ctxr E. coli, but lower odds 
of Tcr E. coli (if housed with calves older than one month). There were no 
significant differences in AMR E. coli shedding between bull and heifer calves. 
Farm characteristics  
In general, shedding of AMR E. coli was more common in large than small 
herds. Calves on farms in some regions were more likely to shed QREC (South 
and East > North Sweden) and chloramphenicol resistant (Cmr) E. coli (North 
and East > South Sweden) than calves in other regions. Higher odds of 
ciprofloxacin (Cir) and nalidixic acid resistant (Nalr), but lower odds of Cmr E. 
coli, were observed on farms with predominantly the Swedish Holstein breed 
than on farms with either Swedish Red or mixed breeds. For QREC, a 
significant interaction was found between predominant herd breed and 
geographic location. Calves on farms with tie-stall milking or automatic 
milking systems (AMS) had lower odds of ampicillin resistant (Amr) or Tcr E. 
coli than farms with parlour milking. No differences in the occurrence of AMR 
E. coli were found between non-organic and organic farms. 
Feeding waste milk from antimicrobial-treated cows to calves  
Neither feeding WC nor WT to calves affected the faecal shedding of AMR E. 
coli among calves.  
In the univariable analyses in paper II, feeding WM to calves increased 
faecal shedding of AMR E. coli, but no difference was found between calves 
on farms that fed TWM and those on farms that only fed WWM. Thus, these 
two categories were amalgamated to one category (WM) in the multivariable 
analysis. Higher within-sample prevalence of Smr E. coli and QREC and 
higher odds of Nalr and Smr E. coli were observed for calves on farms that fed 
WM to calves compared to calves on farms where WM always was discarded. 
A significant interaction between using fluoroquinolones in cows and feeding 
WM to calves was also found for QREC. 
Using antimicrobial-treated cows for nursing was not associated with the 
occurrence of AMR E. coli. 
Use of antimicrobials  
Systemic fluoroquinolone treatment of cows was associated with more faecal 
QREC among calves, but the shedding of QREC by calves varied on farms that 
used fluoroquinolones regularly (Figure 3). This made us look more in detail 
(papers III and IV) to determine which other factors were associated with the 
shedding of QREC. 
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 Systemic tetracycline treatment of cows was associated with increased 
odds of Nalr, Cir, or Tcr E. coli and systemic tetracycline treatment of calves 
led to higher odds of Tcr or Cmr E. coli. Systemic ceftiofur treatment of cows 
increased the odds of Amr E. coli, and using ceftiofur in calves increased the 
odds of Ctxr E. coli. Systemic trimethoprim-sulfonamide treatment of calves 
was associated with increased within-sample prevalence of QREC. Short-
acting DCT and treating a higher proportion of cows in the herd with long-
acting DCT resulted in more calves with Smr E. coli. Orally administered DHS 
to calves was associated with higher within-sample prevalence of QREC and 
Smr E. coli, and with higher odds of Nalr, Cir, or Smr E. coli. Use of systemic 
benzylpenicillin in combination with DHS in calves also gave higher within-
sample prevalence of Smr E. coli. However, the use of systemic 
benzylpenicillin in cows and calves, intrauterine tetracycline treatment of 
cows, and intramammary antimicrobials (penicillin only or penicillin-DHS 
combination) for the treatment of cows during lactation was not associated 
with any of the resistance traits. 
4.3 Farming practices related to feeding waste milk 
Of the 457 Swedish dairy farmers that completed the questionnaire in paper I, 
89% fed WC and 85% fed WT at least occasionally to calves. The most 
important reason not to feed WC was if it was of insufficient quality (as 
determined by the farmer) or if alternative colostrum was available. If WT was 
not always fed, it was only fed to certain calves (in particular bull calves). 
Waste colostrum and WT were fed to calves more often on non-organic than 
organic farms and on more farms with tie-stall barns than free-stalls. 
Figure 3. Proportion of calves with at least one quinolone resistant E. coli (QREC) relative to
calves with only quinolone susceptible E. coli on farms that used fluoroquinolones (FQ) regularly
for cows and those that never used  FQ for cows (paper II). 
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Waste milk from cows treated during lactation was at least occasionally fed 
to calves 56% of the farms (TWM) and on 79% of the farms (WWM). All 
farms that fed TWM also fed WWM to calves. The most important reason for 
not feeding TWM to calves was to avoid feeding them milk from cows with 
mastitis. For WWM, a common practice was to only give such milk to certain 
calves (in particular bull calves). Seven percent of the farmers reported that 
antimicrobial-treated cows occasionally were used as nursing cows. Feeding 
TWM and WWM was more common on non-organic than organic farms, on 
farms with cows housed in tie stall compared to free stall barns, and on farms 
located in South Sweden compared to other regions.  
4.4 Risk factors for QREC (paper III) 
Risk factors for QREC in calves 0 to 30 days old 
Calves between 18 and 30 days of age had a significantly higher within-sample 
prevalence of QREC than calves 0 to 17 days old. The use of fluoroquinolones 
in the herd during the previous four months also resulted in a higher within-
sample prevalence of QREC. Waste milk feeding on the farm-level, as well as 
on the individual calf-level, resulted in a higher within-sample prevalence of 
QREC. Individual calves— independent of whether it was fed WM or not— all 
shed QREC at negligible levels at approximately three weeks of age. 
There were two significant risk factors for carriage of at least one QREC in 
preweaned calves. The first was carriage of QREC by at least one of the 
sampled post-partum cows on the farm. The second was use of the calving pen 
as a sick pen rarely rather than often.  
Risk factors for QREC in post-partum cows 0 to 3 days after calving 
Since the carriage of QREC in preweaned calves was associated with carriage 
of QREC in post-partum cows, risk factors for QREC shedding by post-partum 
cows were also investigated. Calving in a group (free stall or group calving 
pen) compared to calving in single pens or tie stalls led to higher odds of 
QREC in the cow faeces. Other risk factors for QREC shedding in cows were 
poorer than average farm hygiene, purchase of cattle, and sharing animal 
transports with other livestock farmers. 
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4.5 Dissemination and genetic diversity of QREC (paper IV) 
4.5.1 QREC contamination of the farm environment and milk  
The proportion of samples positive for QREC for different sampling sites was 
48% for calf feed troughs, 55% for calf water troughs, 32% for milk buckets, 
55% for automatic milk feeders, 52% for calf pen walls (single and group 
pens), 50% for calving pen walls, 52% for calving pen floors, 39% for lactating 
cow pen floors, 26% for dry cow pen floors, and 35% for young stock pen 
floors (all ages). In addition, 3% of all colostrum and milk samples contained 
QREC.   
Quinolone resistant E. coli was significantly more common on H- than L-
farms in feed and water troughs in the calf area, in milk buckets, on the walls 
of calf single and group pens, on the calving pen floors and on the floors of 
pens for young stock aged 1 to 6 months. There were no differences between 
H- and L-farms for samples from the automatic milk feeders, the calving pen 
walls, or from the floors in the dry and lactating cow areas and in pens with 
young stock aged 7 to 24 months. The proportion of milk and colostrum 
samples with QREC was similar on H- and L-farms. The proportion of positive 
samples, the median and max within-sample prevalence in samples from the 
farm environment is described in Table 2.  
Table 2. Proportion of positive samples, the median and max within-sample prevalence of 
quinolone resistant E. coli (QREC) in environmental samples from farms where QREC is 
common in faecal samples from preweaned dairy calves (H) compared to farms QREC is rare in 
faecal samples from such calves (L). 
Sample type (number of samples) 
H-farms  L-farms 
% 
pos-
itive 
Median 
(%) 
Max 
(%) 
 % 
pos-
itive 
Median 
(%) 
Max 
(%) 
Calf feed troughs (23) 82 10 100  17 0 0.2 
Calf water troughs (20) 100 5 100  10 0 0.05 
Calf milk buckets (22) 70 4 33  0 0 0 
Calf automatic milk feeders (11) 83 3 26  20 0 0.005 
Calf single pen walls (22) 82 4 17  27 0 45 
Calf group pen walls (23) 82 1 49  25 0 0.33 
Calving pen walls (22) 60 0.8 42  42 0 40 
Calving pen floors (23) 82 0.08 30  25 0 0.36 
Lactating cow pen floors (23) 55 0.02 5  25 0 4 
Dry cow pen floors (19) 33 0 20  20 0 13 
Young stock 1 to 6 months pen floors (23) 64 0.04 2  8 0 0.006 
Young stock 7 to 24 months pen floors (23) 45 0 0.1  25 0 2 
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4.5.2 Genetic diversity and dissemination of QREC  
A total of 136 isolates from H-farms were genotyped by MLVA. Twenty-three 
unique MLVA types were identified. The within-farm diversity index (DI) was 
calculated as the proportion of unique MLVA types of the tested isolates on 
each farm. Two to nine unique MLVA types were found on each farm, 
resulting in a DI between 0.1 and 0.6. Six MLVA types were identified on 
more than one farm, whereas the remaining types were found only on a single 
farm. One MLVA type was identified on six farms, another on five, and four 
different types were found on two farms each.  
Farm-pairs with shared MLVA type were located significantly closer to 
each other than farm-pairs without shared MLVA types (196 km vs. 276 km). 
There was a strong positive correlation (ρ = 0.81) between the number of 
purchased cattle since 1998 and the DI. A group of cattle had been traded once 
between two farms in the study and on these two farms, 90% of the total 
number of isolates tested had the same genotype. 
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5 Discussion 
The papers in this thesis demonstrate that AMR E. coli is commonly isolated 
from faeces of preweaned dairy calves. A number of risk factors at the farm 
and calf level have been identified and the dissemination of QREC has been 
assessed. Here, the most important results are discussed in a general manner 
across papers and across aims. The focus of the discussion was to find 
measures to reduce the overall burden of AMR E. coli on dairy farms. 
5.1 Factors related to the occurrence of AMR E. coli 
One specific aim of this thesis was to describe the occurrence of AMR E. coli 
in relation to various risk factors. Several factors were shown in this thesis to 
have an impact on the occurrence of AMR E. coli, but special focus was on the 
age of the calf, use of antimicrobials in the herd and the use of WC, WT and 
WM as calf feed.  
5.1.1 Age-related dynamics of AMR E. coli 
The age of the calf was an important factor for the shedding of AMR E. coli. 
Not only did calves carry more QREC than post-partum cows (paper III), but 
most resistance traits also declined with increasing age of the calf (papers II 
and III). The more frequent isolation of resistant E. coli from young compared 
to old animals is consistent with earlier studies on cattle as well as humans and 
pigs (Reves et al., 1990; Moro et al., 1998; DeFrancesco et al., 2004; Sato et 
al., 2005; Dolejská et al., 2008; Gow et al., 2008; Berge et al., 2010; Hansen et 
al., 2013; Yamamoto et al., 2013). Given that calves and cows are exposed 
more or less to the same microbiota on the farm, the difference probably relies 
on factors related to colonization ability of AMR E. coli in the gut at various 
ages (Edrington et al., 2008).  
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The ability for a strain to colonize the gut depends on the colonization 
resistance in the GI tract, i.e. competition from the indigenous microbiota, but 
also the host immune system (Buffie & Pamer, 2013). The GI microbiota of 
newborn calves is non-versatile and low in bacterial counts and therefore offers 
a less developed colonization resistance than the GI microbiota of older cattle 
(Lukáš et al., 2007; Edrington et al., 2012a; Mayer et al., 2012; Oikonomou et 
al., 2013; Klein-Jöbstl et al., 2014b). Moreover, although all essential 
components of the immune system are present at birth, they may not be 
functional until two to four weeks later (Reber et al., 2006). Young calves are 
therefore more vulnerable than older, healthy cattle to the establishment of 
unwanted strains, such as pathogenic bacteria or AMR E. coli, in the GI tract 
(Edrington et al., 2008). Two other examples are the establishment of 
diarrhoeagenic E. coli, which is most common during the first postnatal week 
(Wieler et al., 2007) and the more frequent occurrence of Salmonella infection 
in young calves than older cattle (Edrington et al., 2008).  
However, underdeveloped colonization resistance and immature mucosal 
immune system do not in and of themselves explain why AMR E. coli strains 
are favoured over susceptible ones in the young calf gut. A possible 
explanation is that AMR E. coli strains sometimes carry more virulence 
factors, e.g. adhesion factors, than susceptible E. coli strains (Nowrouzian et 
al., 2005; Karami et al., 2006; de Verdier et al., 2012; Lastours et al., 2014). 
Human QREC strains are also significantly more resistant to acid and are better 
at using the main nutrient source in the gut than quinolone susceptible strains 
(Lastours et al., 2014).  Eberhart et al. (2012; 2014) observed that a bacteriocin 
produced by some AMR E. coli strains from calves can inhibit growth of 
susceptible E. coli. Hence, AMR E. coli strains seem to possess colonization 
factors or inhibiting substances that balance the cost of producing resistance 
elements. All these factors may facilitate their survival and establishment in the 
GI tract and explain their selective advantage over susceptible strains, even in 
the absence of a selective pressure from exposure to antimicrobials. 
A decline in the prevalence of resistant E. coli with increasing age has also 
been observed by others (Hinton et al., 1985a; b; Hoyle et al., 2004a; b; Berge 
et al., 2005a; Watson et al., 2012; Brunton et al., 2014). In paper II, resistance 
in E. coli was most common at around one week of age, which coincides with 
the peak occurrence of E. coli in general in the GI tract of calves (Lukáš et al., 
2007; Mayer et al., 2012). The displacement of resistant E. coli strains by 
susceptible ones (Hinton et al., 1985a; b) may be a consequence of increasing 
activity of the immune system and competition from the indigenous microbiota 
as the latter expands in number and diversity. The species mainly responsible 
for the colonization resistance are the anaerobic ones (Andremont, 2003), 
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which increase rapidly in numbers during the second and third week of the 
calf’s life (Lukáš et al., 2007; Oikonomou et al., 2013; Klein-Jöbstl et al., 
2014b). In general, the GI microbiota increases in diversity and species 
richness at this time point (Edrington et al., 2012a; Oikonomou et al., 2013; 
Klein-Jöbstl et al., 2014b). Hence, colonization resistance is probably 
enhanced after two to three weeks of age. Runnels et al. (1980) observed that 
some E. coli strains colonize less and less efficiently with increasing calf age. 
These authors propose that host-resistance to specific strains is mediated by the 
innate immune system (Runnels et al., 1980). Because AMR E. coli strains 
carry more virulence factors (Karami et al., 2006; de Verdier et al., 2012; 
Lastours et al., 2014), it can be assumed that AMR strains also stimulate the 
immune system more than susceptible ones. Thus, increased host resistance to 
AMR E. coli with increasing age may to some extent explain the age-related 
decline in AMR E. coli. Since neither colonization resistance (Lukáš et al., 
2007; Oikonomou et al., 2013; Klein-Jöbstl et al., 2014b) nor the innate 
immune system is very active before two weeks of age (Reber et al., 2006), 
inhibition of most resistant strains cannot occur until after that. All the above 
changes coincide with the sudden decline in the within-sample prevalence of 
QREC observed in paper III. 
5.1.2 Antimicrobial use and its implications for AMR E. coli 
In papers II and III, sampled calves were supposedly healthy and untreated 
with antimicrobials. The aim was therefore not to assess the impact of 
individual treatments on the calf gut microbiota, but to assess the impact of 
farm-level use of antimicrobials on the overall occurrence of faecal resistant E. 
coli in preweaned calves. The relative importance of farm-level as opposed to 
individual-level antimicrobial use in the occurrence of AMR E. coli is 
confirmed by Tragesser et al. (2006). In papers II and III, we observed that 
farm-level use of antimicrobials influenced the occurrence of AMR E. coli in 
faeces of calves. Not only antimicrobial treatment of preweaned calves, but 
also treatment of cows increased faecal shedding of AMR E. coli by the calves. 
Although antimicrobial treatments of individuals only transiently select for 
AMR E. coli in the GI microbiota (Berge et al., 2006; Singer et al., 2008), 
resistant strains will concentrate in faeces and subsequently, the farm 
environment. Resistant E. coli from these cows may then enter the GI tract of 
other individual animals. As stated by Lipsitch & Samore (2002), treatment of 
one individual in the herd may increase the ratio of resistant to susceptible E. 
coli in the surroundings, thereby facilitating colonization with AMR E. coli in 
the animals sharing the same environment. Since AMR E. coli may outcompete 
susceptible ones in the calf gut (Khachatryan et al., 2004), it is therefore likely 
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that AMR E. coli strains from other animals in the herd may enrich in the calf 
gut.  
Streptomycin resistance was a common finding in the E. coli from calves 
(paper II). Such resistance emerges rapidly as a consequence of treatment with 
streptomycin or DHS, for which cross-resistance to streptomycin is almost 
complete (Giguré et al., 2006). Oral DHS-treatment of calves, systemic 
treatment of calves with benzylpenicillin/DHS combinations, as well as DCT 
with long- and short-acting intramammary tubes (often containing DHS) 
increased shedding of Smr E. coli (paper II). Oral DHS-treatment for calf 
diarrhoea is not recommended in Sweden (Sveriges Veterinärmedicinska 
Sällskap, 2013); it is not likely to be effective given the high Smr levels 
obtained in this study and in clinical isolates from the GI tract of calves 
(Swedres-Svarm 2013). Oral administration of DHS to calves also increased 
the shedding of Nalr and Cir E. coli. Previous studies have shown that oral 
DHS may select for E. coli resistant to multiple types of antimicrobials, 
probably because of limited absorption from the gastrointestinal tract (Gaines 
et al., 1978). Only 19% and 18% of the farms in paper II used oral DHS or 
systemic benzylpenicillin/DHS, respectively, which indicates that these drugs 
can be avoided without severe consequences for calf health. A synergy 
between penicillin and DHS has been proposed, but has not been proven in 
vivo for treatment of mastitis (Whittem & Hanlon, 1997). Long-acting 
intramammary antimicrobials without an aminoglycoside component are, 
however, not available in Sweden. Overall, the results indicate that the 
inclusion of the DHS components in products for dairy cows and calves 
scarcely can be justified from a resistance point of view. 
In paper II, we observed that the use of certain antimicrobials was 
associated with resistance to unrelated drugs, in line with the results of Bosman 
et al. (2014). Systemic treatment with tetracycline not only increased the odds 
of Tcr E. coli, but also the odds of E. coli with unrelated resistance traits, such 
as Nalr, Cir and Cmr. This is probably due to co-resistance between Tcr and 
unrelated antimicrobials as 55%, 51%, and 91% of the Nalr, Cir and Cmr 
isolates, respectively, were also Tcr (results not shown). Likewise, tetracycline 
and chloramphenicol resistance is very common in QREC isolates from cattle 
in other countries (Hordijk et al., 2012; Marchese et al., 2012). Another 
explanation is that so called Mar (multiple antibiotic resistant) mutants may 
emerge following tetracycline exposure (George & Levy, 1983). Isolates with 
the Mar locus exhibit decreased expression of the OmpF porin, which results in 
less accumulation of the drug in bacterial cells (Cohen et al., 1988). This 
mechanism has been associated with resistance to tetracycline, 
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chloramphenicol, quinolones, betalactams, and rifampicin (George & Levy, 
1983).  
Use of fluoroquinolones in cows was a risk factor for shedding of QREC in 
both papers II and III. The use of these drugs has also been associated with a 
higher prevalence of QREC in other studies, either after treatment of the 
individual calf or on the farm-level (Pereira et al., 2011; Cummings et al., 
2013; Jones et al., 2013; Yamamoto et al., 2013; Bosman et al., 2014). Until 
2012, fluoroquinolones were the second most prescribed antimicrobial drug 
class for systemic use in dairy cows enrolled in SOMRS (Växa Sverige, 2015), 
and they were used regularly for the treatment of coliform mastitis. In January 
2013, prescription of this drug was restricted due to its importance in human 
medicine (Swedish Board of Agriculture, 2013). The prescription of 
fluoroquinolones has since then decreased (Växa Sverige, 2015), but it is 
uncertain whether the decrease is due to these restrictions or other factors.  
The within-sample prevalence of QREC in calves was also higher on farms 
that treated calves with systemic trimethoprim-sulfonamides products (paper 
II). This association is probably due to co-resistance, as 38% of the Sur isolates 
were also Nalr (results not shown). Likewise, sulfonamide and trimethoprim 
resistance is very common in QREC isolates from cattle in other countries 
(Hordijk et al., 2012; Marchese et al., 2012). 
Farms that reported treatment with systemic ceftiofur (a third-generation 
cephalosporin) of calves were more likely to have calves with Ctxr E. coli, 
which is in line with the findings of Tragesser et al. (2006). Farms that had 
used third- and fourth-generation cephalosporins were also nearly four times 
more likely to have ESBL-producing E. coli than farms that had not used such 
drugs (Snow et al., 2012). In our study, farms that used ceftiofur in cows had 
more calves with Amr E. coli than farms that did not. Many third- and fourth- 
generation cephalosporins alter the composition of the GI microbiota, in 
particular the anaerobic part which is important for colonization resistance 
(Edlund & Nord, 1993). The higher prevalence of Amr E. coli on farms that use 
ceftiofur in cows may be explained by enrichment of Amr strains in the cow 
gut facilitated by ceftiofur-mediated decrease in gut colonization resistance. 
Ceftiofur is the only licensed third-generation cephalosporin, while no fourth-
generation cephalosporin is available for use in dairy cattle in Sweden (FASS 
vet, 2015). Ceftiofur is used restrictively on Swedish dairy farms (Växa 
Sverige, 2015), which probably explains the low prevalence of ESBL-
producing E. coli in calves in this study (1%).  
Benzylpenicillin is by far the most used drug for cattle in Sweden (Växa 
Sverige, 2015) and this was also the case in paper II (results not shown). 
However, we did not find a significant association between the use of systemic 
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benzylpenicillin and faecal AMR E. coli in calves (paper II). This is contrary to 
the results of Grønvold et al. (2011) who isolated significantly more resistant 
E. coli in faeces from calves after systemic penicillin treatment. However, their 
conclusion is based on susceptibility testing of single E. coli isolates before and 
after treatment (Grønvold et al., 2011), a method associated with a high degree 
of uncertainty. Benzylpenicillin administered parenterally is excreted quickly, 
almost entirely via the kidneys, whereas other antimicrobials are excreted, to 
some extent, via the GI tract (Giguré et al., 2006). Thus, parenterally 
administered benzylpenicillin is likely to have minimal impact on the GI tract 
microbiota, as shown in humans (Edlund & Nord, 1993).   
Overall, the results indicate that the use of broad-spectrum antimicrobials 
should be limited both in the cow and calf populations. In line with current 
guidelines on antimicrobial use in cattle in Sweden, the use of benzylpenicillin 
should instead be promoted.   
5.1.3 Waste milk feeding and its implications for AMR E. coli 
Feeding colostrum and transition milk 
To our knowledge, paper II is the first to investigate the effects of feeding WC 
or WT to calves on faecal AMR E. coli from preweaned calves. Blanket DCT 
is common in most other countries, whereas in Sweden, sales records show that 
26% of the dairy cows are treated with antimicrobials at drying off (selective 
DCT) (Växa Sverige, 2015). Hence, farmers in Sweden have the option of 
feeding colostrum and transition milk from untreated cows, which is not the 
case in blanket DCT. Still, the vast majority of the farms in the survey in paper 
I reported that WC or WT was fed to calves at least occasionally. Feeding only 
colostrum from non-treated cows to calves would require storing large volumes 
of colostrum from non-treated cows, which is not feasible on some dairy farms.  
In paper II, we did not find a significant difference in the occurrence of 
AMR E. coli between farms that fed WC or WT at least occasionally and farms 
that did not. If the cow is dried off 60 days before calving, and the withdrawal 
period is between 35 and 37 days, the antimicrobial may already be eliminated 
at calving. This is confirmed by Olivier et al. (1984) who were unable to detect 
antimicrobial residues in colostrum from the first milking, even after dry 
periods of varying length. If the antimicrobials are given according to the 
manufacturer’s recommendations, WC or WT feeding is safe from a resistance 
point of view. However, care must be taken when extrapolating these results to 
other countries where broader-spectrum antimicrobials are used or where most 
or all calves are given WC or WT.  
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The current recommendations state that WC, as defined in this thesis, 
should not be fed to calves at all, whereas WT can be given to calves from the 
third milking after calving 7 . Based on our results, we suggest that these 
recommendations be abolished. Instead, WC and WT can be given to calves 
without restrictions.  
Feeding waste milk from cows treated during lactation 
Waste milk was at least occasionally fed to calves on 79% of the farms in 
paper I, which is similar to a survey in the UK and Wales (83%) (Brunton et 
al., 2012). Interestingly, over one-fourth of the organic farmers (paper I) stated 
that they fed WM during on-going treatment although this is prohibited on 
organic farms (KRAV, 2015). If this result is not due to a misinterpretation of 
the question, it indicates a lack of compliance with current regulations for 
organic certification.  
More farms with cows housed in tie stall than free stall barns fed WM to 
calves. It can be hypothesized that there is a generation shift between tie stall 
and free stall farms, and that younger farmers are more aware of risks of 
feeding WM to calves. Finally, there were regional differences in feeding of 
WM to calves. It is possible that farmers in proximity to each other shared 
similar strategies, eventually as a result of using the same advisory services. 
In our studies, we observed that feeding WM to calves increased the 
shedding of Smr E. coli (paper II) and QREC (papers II and III) by preweaned 
calves, but did not affect the shedding of E. coli with other resistance traits 
(paper II). Since the initiation of this project work, several studies have 
investigated the effect of WM feeding on the occurrence of resistant bacteria in 
faeces of calves. The conclusions drawn by these studies all point in the same 
direction—WM feeding favours faecal E. coli with certain resistance traits 
(Aust et al., 2012; Brunton et al., 2014; Pereira et al., 2014d; Rebelo, 2014). 
Brunton et al. (2014) also observed that the shedding of ESBL-producing E. 
coli persists longer in WM-fed than non-WM-fed calves. 
 Twenty-three percent of the farms in paper I reported that they fed WM 
during the withdrawal period only, possibly to reduce the exposure of calves to 
antimicrobial residues. Nonetheless, we did not find a significant difference in 
the occurrence of AMR E. coli on farms that chose to discard TWM and to 
only feed WWM to calves compared to those that fed both TWM and WWM. 
Both these practices increased the occurrence of AMR E. coli among calves. 
This suggests that even the lower concentrations of residues in WWM are 
sufficient to exert a selection pressure on the GI microbiota. Hence, our results 
are in agreement with those by Pereira et al. (2014d) who show that even very 
                                                        
7. Håkan Landin, Växa Sverige, personal communication 
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low concentrations of antimicrobials in milk favour AMR E. coli in faeces of 
calves. 
Since benzylpenicillin is by far the most common antimicrobial used in 
dairy cows in Sweden (Växa Sverige, 2015), this is probably the drug that most 
Swedish calves are exposed to if fed WM. We therefore assume that the higher 
levels of AMR E. coli on farms feeding WM to calves at least occasionally, 
compared to those that discarded all WM was mainly due to exposure to 
benzylpenicillin residues. Although benzylpenicillin is to some extent degraded 
in the GI tract, the bioavailability of benzylpenicillin administered in milk is 
10% in one-week old calves (Musser & Anderson, 2001). Since penicillin is 
absorbed mainly from the intestines (McDermott et al., 1946), this means that 
at least a portion of the drug reaches there. Langford et al. (2003) also show 
that milk containing penicillin affects the composition of the faecal flora, 
further indicating that the penicillin is reaching the intestines. All members of 
the species E. coli are intrinsically resistant to benzylpenicillin (Giguré et al., 
2006), but benzylpenicillin in milk may inhibit benzylpenicillin-susceptible 
species in the gut, which decreases the colonization resistance and facilitates 
colonization with AMR E. coli. Feeding WM from cows treated with broad-
spectrum antimicrobials probably exerts a similar effect on the colonization 
resistance in the gut of calves, but with a direct selection of resistant E. coli 
superimposed on it. The significant interaction effect between WM feeding and 
use of fluoroquinolones in cows on the shedding of faecal QREC (paper II) 
further suggests that this is the case.  
The calf GI microbiota is very simple until two to three weeks of age 
(Edrington et al, 2012a; Oikonomou et al., 2013; Klein-Jöbstl et al., 2014b) 
and thus, probably more vulnerable to inhibition by antimicrobials than in 
older animals. Based on the results of paper III, we therefore hypothesized that 
calves fed WM before two to three weeks of age were at higher risk of 
acquiring AMR E. coli than older calves, but this requires further study for 
confirmation. 
British farmers reported that saving money was the most important reason 
for feeding WM to calves (Brunton et al., 2012). The economics in Swedish 
dairy farming are currently very strained and every effort to save money is 
important. Thus, feeding WM to calves is an attractive way to reduce costs also 
for Swedish farmers. Godden et al. (2005) observed that calves fed 
conventional milk replacer have higher morbidity and mortality rates, and 
lower growth rates than calves fed pasteurized WM. They estimate that net 
savings from feeding pasteurized waste milk is $0.69 per calf and day 
compared to milk replacer (Godden et al., 2005). Hence, the farm economy 
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may benefit from WM feeding, but at the cost of an increased burden of AMR 
E. coli to the society as a whole. 
One way of minimizing the burden of AMR E. coli on dairy farms without 
compromising the farm economy could be to inactivate antimicrobials in WM 
before feeding it to calves. Pasteurizing or acidifying WM as well as adding 
inactivating enzymes to WM have been proposed for this purpose. 
Pasteurisation decreases the bacterial load of milk fed to calves (Godden et al., 
2005), but betalactams, aminoglycosides and quinolones are very heat-stabile 
and normal pasteurisation is insufficient to inactivate them in WM (Zorraquino 
et al., 2008, 2009; Roca et al., 2010, 2011). Benzylpenicillin is inactivated by 
acid (Giguré et al., 2006) and hence, acidifying WM by fermentation or adding 
acid may reduce the benzylpenicillin concentration. However, WM 
fermentation may require up to 100 hours due to penicillin-inhibition of 
fermenting bacteria (Keys et al., 1976, 1979). Fermentation of WM is therefore 
only a good alternative for inhibition of benzylpenicillin when the 
concentration in WM is low. Likewise, adding formic acid to WM requires one 
to seven days to inactivate benzylpenicillin (Raustein, 2003). A more 
promising method is to add a betalactamase enzyme (Antipen, Finnzymes, 
Esbo, Finland). This is reported to inactivate the drug residues within three 
hours (Raustein, 2003). This is a quick approach, but the effect of feeding 
betalactamase-treated WM on the occurrence of faecal AMR E. coli still needs 
to be evaluated.  
The current Swedish recommendation is that WM should not be fed until 
the second post-treatment day8. Based on our results, we suggest instead that 
WM should not be fed to calves, at least not during the first few weeks of life 
when they may be more susceptible for colonization with AMR E. coli. 
However, if penicillin residues can be inactivated, WM from benzylpenicillin-
treated cows can probably be fed to calves. Waste milk from cows treated with 
broad-spectrum antimicrobials should, on the other hand, always be discarded.  
5.2 Factors related to the dissemination of AMR E. coli, with 
special reference to QREC 
Another aim of this thesis was to describe the within-farm dissemination of 
QREC and factors of relevance for its spread. The results may also apply to 
other resistant bacteria that behave in a similar manner. The following is a 
discussion on the dissemination of AMR E. coli that focuses on measures to 
reduce the burden of those bacteria on dairy farms. 
                                                        
8. Håkan Landin, Växa Sverige, personal communication 
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5.2.1 Acquisition of QREC by calves 
Shedding of AMR E. coli occurs shortly after birth as shown in paper III and 
by others (Donaldson et al., 2006; Watson et al., 2012; Brunton et al., 2014). 
One-fifth and one-third of the calves shed QREC already on the day of birth 
and day one, respectively (paper III). The normal retention rate in the GI tract 
for milk-fed calves is nine hours (Cannon et al., 2010), indicating that calves 
acquired AMR E. coli strains relatively early after birth. Colonizing bacteria 
may originate from the vaginal or GI tract of the mother, from her skin or 
colostrum during ingestion of the first meal, or from the surroundings to which 
the calf is exposed (Mackie et al., 1999). In paper IV, we observed that QREC 
were widespread in the surroundings on H-farms, in particular in the calf- and 
calving pens, resulting in ample oppurtinities for the newborn calf to pick up a 
resistant strain from the surroundings.  
The maternal faecal microbiota may affect the composition of the 
offspring’s GI tract microbiota (Bettelheim et al., 1974; Callens et al., 2014), 
but this may not be the only source of AMR E. coli for calves (Gow et al., 
2008; Watson et al., 2012). Gow et al. (2008) found no association between the 
resistance patterns of E. coli from the newborn beef calf and its dam. Watson et 
al. (2012) observed that, in most cases, dairy calves and their dams shed 
different clones of ESBL-producing E. coli. Both Gow et al. (2008) and 
Watson et al. (2012) conclude that the farm environment microbiota is more 
important than the dam’s microbiota for the occurrence of AMR E. coli in 
calves. We observed that QREC was more common on the calving pen floors 
of H- than L-farms, and the calving pen environment is probably a source of 
colonizing QREC for newborn calves. Bacteria in the calving area may either 
be derived from cows or calves that has been kept previously in the calving 
area. In this study, many post-partum cows shed QREC in faeces and the 
prevalence among these cows seemed slightly higher than in lactating and dry 
cows, indicating that the shedding of QREC increases around calving. In a 
small-scale study, the shedding of faecal Tcr E. coli was compared between 
peri-partum and mid-lactation cows from the same farm (Gustafsson, 2014). 
The results showed that none of the mid-lactation cows shed Tcr E. coli, 
whereas 18% of the post-partum cows shed Tcr E. coli approximately one week 
after calving (Gustafsson, 2014). An increase in the shedding of AMR E. coli 
after calving is also reported by Watson et al. (2012). However, both in that 
study and in paper III, calves shed significantly more AMR E. coli than post-
partum cows, suggesting that calves are the main sources for AMR E. coli in 
the calving area. Rather than being the actual source of QREC, it can be 
speculated that the post-partum cows become colonized with QREC in the 
calving area. Peri-partum cows compared to mid-lactation cows may be at 
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higher risk of colonization with AMR E. coli, as a consequence of disturbances 
in the GI flora induced by changes in diet, stress by movement to the calving 
area etc. (Anderson et al., 1984). Moro et al. (1998, 2000) also observed that 
the occurrence of AMR E. coli in faeces from pigs increases when they are 
cold- or heat-stressed, and one can assume that stress has a similar effect on the 
GI microbiota of cows. 
We also hypothesized that calves become colonized with QREC by 
ingestion of contaminated milk, but the lack of QREC in most milk samples in 
paper IV suggests that this is not the case. Rather, it seems that the composition 
of the farm environment microbiota is the most important source for AMR E. 
coli in calves. To reduce the risk of acquisition of AMR E. coli strains a clean 
calving environment should be provided. 
5.2.2 Dissemination of AMR E. coli within farms 
Within-farm dissemination of QREC correlated with the shedding of QREC by 
calves. We also found that QREC shedding by at least one post-partum cow 
was a risk factor for QREC shedding by calves, indicating that the presence of 
QREC in one category affects its occurrence in other categories on the farm. 
The overall genetically homogenous population of QREC in different samples 
from the same farm suggests that QREC is disseminated clonally throughout 
farms, in line with the findings by Hoyle et al. (2005). Clonal dissemination of 
QREC strains within-farms is probably facilitated by poor farm hygiene, which 
was also a significant risk factor for QREC shedding by post-partum cows. 
Poor farm hygiene is also a risk factor for shedding of quinolone resistant 
Campylobacter in pigs (Taylor et al., 2009). Bosman et al. (2014) also found 
that poor farmworker hygiene, i.e. changing clothes infrequently, increases 
fluoroquinolone resistant E.coli in veal calves. 
The calf environment—in particular feed troughs, water troughs and milk 
buckets—were more often contaminated with QREC on H- than L-farms, 
which indicates that QREC circulates on a faecal-oral route in the calf area. 
Watson et al. (2012) likewise observed that water troughs are heavily 
contaminated with ESBL-producing E. coli on a farm where ESBL-producing 
E. coli are commonly isolated from individual cattle. Snow et al. (2012) also 
concluded that infrequent disinfection of milk feeding equipment is a risk 
factor for the occurrence of ESBL-producing E. coli on dairy farms. Although 
not elucidated in this study, cleaning and disinfection of feed troughs, water 
troughs and milk buckets could reduce the burden of QREC in the farm 
environment and among calves. Furthermore, reducing the overall 
contamination of E. coli in the surroundings of the calf may be beneficial also 
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in terms of reducing the load of intestinal pathogens (Klein-Jöbstl et al., 
2014a).  
As stated in the previous section, the calving area could be important in the 
acquisition of QREC for cows and calves. Exposure to a QREC-contaminated 
calving area by peri-partum cows may therefore spread QREC to the lactating 
cow pen. As Watson et al. (2012) suggested, transition via the calving area 
may be crucial for the dissemination of AMR E. coli between cattle categories 
on the farm. In paper III, we observed that cows that had calved in groups were 
more likely to shed QREC than cows that calved in tie stall barns or single 
pens. It seems that group calving increased the risk of between-individual 
sharing of faecal flora and thus, colonization with QREC. Moreover, group 
calving may be stressful for the cow as she cannot isolate from the herd, which 
could result in stress-induced changes in the GI microbiota like those observed 
in other species (Moro et al., 1998, 2000; Bailey et al., 2004). Further, new 
cows may enter the group calving pen on a continuous basis instead of using an 
all-in–all-out practice, making it more difficult to keep the pens clean. Using 
the calving pen as a sick pen rarely compared to often was a risk factor for the 
shedding of faecal QREC by calves. This is paradoxical since sick cows are 
sometimes treated with antimicrobials and therefore would be expected to shed 
more AMR E. coli than healthy cows. However, farms that often used the 
calving pen as a sick pen reported that they cleaned it more frequently than 
farms that rarely housed sick cows there. It is likely, therefore, that frequent 
cleaning of the calving area decreases the burden of QREC on the farm, as for 
other faecal-oral transmitted bacteria, such as Mycobacterium avium 
subspecies paratuberculosis (Pithua et al., 2013).  
The movement and inter-mingling of animals and people on the farm may 
also be associated with a higher occurrence of AMR E. coli. Not only do such 
movement disseminate one strain of E. coli to another place on the farm but 
they also increase the contact between potential donors and recipients for 
horizontal transfer of resistance genes. We can assume that movement of 
animals and people is greater in larger herds. We observed in paper II that large 
herds had more AMR E. coli than smaller ones. Furthermore, large herds have 
a higher incidence of disease (Hill et al., 2009; Klein-Jöbstl et al., 2014a), 
probably resulting in higher incidence of antimicrobial treatments. The higher 
occurrence of AMR E. coli in large herds is in line with the results from other 
studies (de Verdier et al., 2012; Rebelo, 2014). Given the rapid increase in herd 
size in Sweden, this finding is a concern.  
Transmission of AMR E. coli may also be facilitated by certain milking 
systems, as calves on farms with milking parlour had more AMR E. coli than 
those with tie stall milking or AMS. Parlour milking may be associated with a 
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greater movement and inter-mingling of cattle and people than tie stall or AMS 
milking where cows are confined to certain cubicles or pens. The type of 
milking system may, however, be a proxy for other, unidentified factors 
affecting the occurrence of AMR E. coli.  
Group housing of the calf also increased Ctxr E. coli shedding, whereas 
group housing with calves older than one month decreased Tcr shedding 
compared to single calf housing. Such inconsistent findings were also observed 
by Pereira et al. (2014c), who conclude that no housing system is preferable. 
Nonetheless, it is likely that inter-mingling with calves in a group pen is 
important for the exchange of E. coli strains and that mixing younger and older 
calves dilutes the resistant E. coli population in the surroundings with 
susceptible strains. 
Overall, the results suggest that the burden and dissemination of AMR E. 
coli may be reduced by improving farm hygiene, with special focus on the calf 
and calving areas, and by using only single pens at calving. 
5.2.3 Dissemination of AMR E. coli between farms 
In paper II, regional differences were observed in the occurrence of QREC and 
Cmr E. coli. Likewise, Yamamoto et al. (2013) found that E. coli with the same 
resistance patterns are genetically similar on farms located in the same 
geographic regions. Clustering of the occurrence of AMR E. coli in different 
regions may result from clonal dissemination of resistant strains between 
closely located farms. Moreover, the same QREC genotype was found on more 
than one farm in paper IV, suggesting clonal dissemination of QREC between 
farms. In line with these findings, Marchese et al. (2012) observed that the 
same clone of QREC caused septicaemic colibacillosis on several farms. In 
addition, Lim et al. (2010) found the same clone on two nearby farms. In paper 
IV, farm-pairs that shared a QREC genotype were also more closely located 
than farm-pairs with no shared QREC genotypes.  
The shorter the distance between farms, the more likely there is to be an 
epidemiologic link between them. Clonal spread of AMR E. coli between 
farms requires an epidemiological link and movement of animals, equipment 
and people between farms is the most straightforward one. In paper III, we 
observed that purchasing cattle and sharing animal transports with other 
livestock farmers increased the odds of QREC-shedding by post-partum cows. 
Interestingly, there was also a strong correlation between the number of 
purchased cattle and the genetic diversity of QREC on the farm, indicating that 
new genotypes were introduced with purchased cattle. These results are in line 
with the findings by DiLabio et al. (2007) who isolated more AMR E. coli 
from calves on farms that purchased calves, in particular from those that 
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purchase from multiple suppliers. In contrast, Snow et al. (2012) showed that 
farms were equally likely to have ESBL-producing E. coli independent of 
whether they had received cattle from a specific farm with ESBL-producing E. 
coli or not. However, if not from that farm, they could have received cattle 
from other farms with ESBL-producing E. coli. These authors found, 
nonetheless, that operating a closed farm policy is protective against the 
occurrence of ESBL-producing E. coli on the farm (Snow et al., 2012), which 
is in line with our findings regarding QREC. 
Two QREC clones were more widespread than others, suggesting that these 
have characteristics that enhance their survival and spread in the farm 
environment. We also observed that, on some farms, many calves shed QREC 
but to a lesser extent. On these farms, QREC was seldomly found in the 
environment. Overall, this probably indicates that some QREC strains are more 
successful than others. In humans, some QREC isolates are more adapted to 
the habitat of the GI tract (Lastours et al., 2014); such differences might also 
exist in the QREC population from cattle. Acquisition of resistance by bacteria 
is mostly associated with a fitness cost, which decreases the growth rate and 
survival of the bacteria (Andersson & Hughes, 2010). The lack-of-fitness cost 
is often necessary for the survival of a mutant in the absence of a selective 
pressure (Andersson & Hughes, 2010). On the other hand, some mutations may 
actually lead to increased fitness. Gullberg et al. (2011) found that the fitness 
cost of strains with a mutation in the gyrA(S83L) is lower than those with the 
gyrA(D87N) mutation. This might explain the widespread occurrence of some 
strains. However, the genetic basis for quinolone resistance was not 
investigated in any of our studies.  
Once established on the farm, QREC may be difficult to eliminate due to its 
adaptability to a commensal habitat (Lastours et al., 2014). Marshall et al. 
(1990) also observed that QREC strains—in contrast to rifampicin resistant E. 
coli— persist in the GI tract of the inoculated heifer and the surroundings for at 
least 70 days post-inoculation, indicating that the survival of bovine QREC 
strains is better than for other E. coli. 
The results emphasise the importance of proper between-farm biosecurity, 
such as minimizing cattle trade and the sharing of equipment between farms. 
Not only does good biosecurity protect against the transmission of infectious 
diseases, but it may also decrease the spread of AMR E. coli in the dairy farm 
population. 
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5.3 Clinical importance of AMR E. coli on dairy farms 
The E. coli isolates in studies in papers II-IV were obtained from commensal 
microbiota and are probably not harmful for the calf itself under normal 
conditions. Nonetheless, a high prevalence of faecal AMR E. coli in the farm 
environment puts the animal at a higher risk of being infected with a resistant 
strain. This is a concern since the proportion of multi-drug resistant isolates of 
E. coli from calf intestinal infections has increased substantially in Sweden 
(Swedres-Svarm 2013).  
Resistant E. coli from calves can also cause infection in older cattle. The 
contamination of AMR E. coli in the calving area may pose a risk for cows to 
acquire an intramammary or intrauterine infection with AMR E. coli. However, 
the occurrence of resistance in E. coli isolates causing intramammary or uterine 
infections in Sweden is low (Swedres-Svarm 2013), suggesting that this is 
currently not a problem on Swedish dairy farms.  
The spread of AMR E. coli to humans may occur through contamination of 
the meat at slaughter; therefore AMR E. coli in faeces of slaughter-ready 
animals is a concern. In Sweden, the majority (80%) of slaughtered cattle are 
above one year of age (Swedish Board of Agriculture, 2014). Hence, a high 
prevalence of AMR E. coli in preweaned calves does not necessarily pose a 
risk for colonization of humans via the food chain, but it may pose a risk for 
humans handling calves (Marshall et al., 1990). On the other hand, bacteria are 
not confined to one cattle category and AMR E. coli may be spread to 
slaughter-ready animals or cows producing milk for humans. It can be assumed 
that the higher proportion of AMR E. coli on the farm, the higher is the risk of 
spreading such bacteria to humans.  
The occurrence of AMR E. coli in faeces of calves may also have 
implications for the spread to the general environment. Cattle faeces (including 
that of calves) is often applied on land as a fertilizer and AMR E. coli from 
calves may therefore end up in soil, water, crops and in wild animals. A high 
proportion of AMR E. coli in calf faeces may therefore increase the ratio of 
resistant to susceptible E. coli in the general environment.  
5.4 Methodological considerations 
The choice of study designs, study populations, and methods for data collection 
affects the validity of the results. Biases are systematic errors that may deviate 
the results more or less from the true situation as a consequence of 
methodological flaws (Dohoo et al., 2010). This section covers methodological 
considerations that could have introduced bias in the results of this thesis. 
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5.4.1 Study populations and study designs 
Selection bias is a concern when the study population deviates too much from 
the target population (Dohoo et al., 2010). Approximating the study population 
to the target is therefore critical in cross-sectional studies where the aim is to 
assess the prevalence of certain traits in the target populations, such as the 
prevalence of AMR E. coli (paper II) or management routines (paper I). The 
target populations in papers I and II were all Swedish dairy farms, and all 
Swedish dairy farms with ≥ 30 cows, respectively. Farms with smaller herd 
sizes were excluded in paper II to make the results of the study more valid in 
the longer term, as farms with < 30 cows would not be representative of future 
Swedish dairy farms. The study populations in all papers were based on farms 
that participated in SOMRS, had registered their e-mail address in the SOMRS 
database, and that responded to the questionnaire in paper I. Thus, this 
approach relied both on the quality of e-mail addresses and the willingness of 
farmers to respond to the questionnaire. The response rate was only 30%, but 
an analysis of respondents and non-respondents proved that they were similar 
in terms of geographic location and herd size. Likewise, there were no 
differences between farms included in papers I and II and their respective 
target populations with regard to herd size and geographic location. Although 
there may be differences in other farm-level characteristics that could distort 
the validity of the study, we believe that the study populations in papers I and 
II were reasonably similar to their targets. 
The study in papers III (and IV) was designed as a case-control study. The 
advantages of case-control studies are that results can be obtained with less 
funding and that multiple exposure factors can be studied using fewer study 
objects (Lewallen & Courtright, 1998). Disadvantages are that incidence data 
cannot be generated and that selection of controls can be challenging (Lewallen 
& Courtright, 1998). For this study, only a small number of farms could be 
included due to time constraints, and since there was only a small number of 
appropriate case farms available, the case-control design was more appropriate 
than a cross-sectional design. The study design (case-control) was therefore 
chosen to ensure that the variation in the prevalence of QREC was large 
enough to identify differences in management routines. This was done at the 
expense of the external validity of the results since the farms were neither 
chosen by random nor to be representative of a larger population. Care should 
therefore be taken when extrapolating the results of papers III and IV to other 
populations.  
The inclusion of farms with a high prevalence of Ctxr in calves and with 
moderate prevalence of QREC in the studies in papers III and IV can be 
questioned. These farms did not meet the criteria for cases or controls, but were 
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visited for a parallel study on the within-farm dissemination of ESBL-
producing E. coli. However, we do not believe that the inclusion of these farms 
markedly affected the results since all farms were recategorized as H- or L-
farms based on samples from 15 calves. Instead, they served to increase the 
sample size. 
5.4.2 Collection of data on antimicrobial usage 
Papers II and III rely on data on the use of antimicrobial drugs; obtaining such 
data with good quality from dairy farms is extremely challenging. Redding et 
al. (2014) reviewed different types of methods for data collection on 
antimicrobial use, such as surveillance at the national level, drug sales records, 
questionnaires or interviews, on-farm treatment records, collection of empty 
drug vials, and detection of tissue residues. Each of these may be more or less 
accessible. Collecting empty vials requires the study to be conducted 
prospectively rather than retrospectively, as in papers II and III. This approach 
also requires that the empty vials are physically collected from the farms which 
may not be feasible when there are many farms.  
In Sweden, antimicrobials for use in animals must be prescribed by a 
veterinarian and registration in the NADRS is compulsory. Thus, in an ideal 
situation, complete data on antimicrobial usage could be obtained from 
NADRS. However, NADRS suffers from under-reporting, in particular for 
antimicrobial treatments of preweaned calves (Mörk et al., 2009). Using 
NADRS records as the only source of antimicrobial consumption data may 
therefore lead to severe underestimation. Questionnaires or interviews on 
antimicrobial use may introduce recall bias (Dohoo et al., 2010), i.e. when the 
farmer does not recall what types and what quantities of antimicrobials that 
was used on the farm. In paper II, two approaches were used: a questionnaire 
and the prescription data from NADRS. The highest estimate from either the 
questionnaire data or the NADRS was used to avoid underestimation of 
treatment incidence. However, it is difficult to assess the precision of this 
method as the true treatment incidence is unknown. 
In paper III, a combination of interviews and on-farm treatment records was 
used to obtain information about antimicrobial usage. The time limit was set to 
four months before the visit, which was considered a reasonable time to 
remember events. Unfortunately, a four-month limit could also lead to over- or 
underestimation due to seasonal effects or disease outbreaks affecting the 
treatment incidence. All farms were visited during the winter season and none 
of the farms mentioned outbreaks during the previous four months. Therefore 
we believe that the measure gave a good estimate of the recent use of 
antimicrobials. 
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5.4.3 Limitations with questionnaire data 
Information (or misclassification) bias may occur in data collected in 
questionnaires, or by using imprecise methods (Dohoo et al., 2010). In this 
thesis, papers I-III included questionnaire or interview data, which may have 
introduced misclassification bias in the results. Several challenges are involved 
in the design of a questionnaire. First, the questions can be misunderstood; 
second, the questionnaire may not include the appropriate options, and third, it 
may be too long and tedious to be completed. To reduce these risks, the 
questionnaires in papers I and III were each pilot-tested on six dairy farmers. 
However, the questionnaire on antimicrobial usage (paper II) consisted of more 
straightforward questions and options that were less likely to be 
misunderstood. This questionnaire was therefore only tested on colleagues at 
SVA.  
As for all questionnaires, there is also a risk that the respondents may 
answer what they believe is the expected or appropriate answer instead of the 
true one. Such errors are more common the more controversial the true answer 
is. It is difficult to assess the magnitude of such errors in the studies in this 
thesis or to what extent they may have changed the final result. However, some 
of the answers of the questionnaires in papers I and II could be regarded as 
controversial, i.e. the use of ceftiofur or feeding of TWM on organic farms, 
indicating that some of the respondents at least to some extent were giving the 
true answer. 
5.4.4 Sampling considerations 
When designing studies, budget and time constraints may limit the total 
number of animals or farms that can be sampled. Thus, either many animals on 
few farms or few animals on many farms can be sampled (Dunlop et al., 1999). 
For monitoring the prevalence of resistant bacteria, the “single sample per 
farm” is the approach recommended by the European Food Safety Authority 
(EFSA, 2014). This approach assumes that isolates from the same farm are 
expected to show a similar resistance pattern due to a common environmental 
microbiota. However, inter-individual differences may be large (Dunlop et al., 
1999). Use of a single sample from each farm in risk factor analyses may lead 
to misclassification of the farm-level resistance status and thus, bias the 
estimates of associations. Therefore, we sampled three calves per farm in paper 
II to increase the precision of the farm-level estimate on the prevalence of 
AMR E. coli. Three to five calves per farm was also the sampling routine 
applied by Di Labio et al. (2007). The results of paper III showed, however, 
that three calves were probably insufficient to determine the farm-level status 
of QREC. Two of the control farms were recategorized as H-farms and one 
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case farm turned into an L-farm when 15 calves per farm were sampled. A 
larger number of sampled calves per farm in paper II could have increased the 
precision of the farm-level resistance status, but would also have reduced the 
number of farms that could be sampled due to increased costs and the 
willingness of farmers to participate. 
5.4.5 Methods for susceptibility testing 
The E. coli population in the GI tract is very numerous, while only a small 
proportion of the total E. coli population is present in the faecal sample (Hinton 
et al., 1985a). This is a major problem when drawing conclusions based on the 
susceptibility of a single random E. coli sample from a calf. Such methods may 
underestimate the true prevalence of AMR E. coli (Scott et al., 2011). A better 
approach is to use selective plates for which the susceptibility of multiple 
isolates can be tested simultaneously (Scott et al., 2011). Nonetheless, selective 
plates require that a breakpoint (concentration of antimicrobial in the plate) 
must be decided ahead of culturing. For some resistance traits there is a clear-
cut difference between the MIC for wild-type and resistant subpopulations, 
whereas they overlap for others. In paper II, > 32 mg/L was the cut-off chosen 
to select for Smr isolates, which is one log2 step higher than the 
epidemiological cut-off issued by EUCAST (EUCAST, 2015). Nonetheless, 
Garcia-Migura et al. (2012) observed that the MIC span of 4 to 32 mg/L may 
represent an overlapping area for the wild-type and resistant subpopulation. 
Thus, a cut-off at > 32 mg/L minimized false-positives at the expense of 
misclassifying some resistant isolates as susceptible. 
Nalidixic acid is the preferred quinolone drug to identify chromosomal 
mutations (Cavaco & Aarestrup, 2009). In papers II-IV, > 32 mg/L was the 
cut-off chosen to select for QREC, one log2 step higher than the 
epidemiological cut-off (EUCAST, 2015). With this approach, some low-level 
resistant isolates may have been misclassified as susceptible and plasmid-
mediated quinolone resistance may have gone undetected (Cavaco & 
Aarestrup, 2009). However, only 0.6% of the 729 isolates in paper II (results 
not shown) had MICs of 32 mg/L, indicating that the proportion of 
misclassified isolates was negligible. Further, plasmid-mediated quinolone 
resistance is very rare in E. coli from cattle (Jurado et al., 2008; Kirchner et al., 
2011; Hordijk et al., 2012; Marchese et al., 2012), so we did not expect this to 
be an issue.   
In paper II, we used selective agars supplemented with 1 mg/L cefotaxime 
without preceding pre-enrichment to select for third- and fourth-generation 
cephalosporin resistance. However, the preferred method for isolation of 
ESBL- or AmpC-producing E. coli is to use selective (containing 
64 
antimicrobials) pre-enrichment in a broth followed by culture on selective agar 
supplemented with antimicrobials (EFSA, 2011). Excluding the pre-enrichment 
step may have led to an underestimation of the prevalence of ESBL-producing 
E. coli in the calf population in Sweden. However, since third- and fourth-
generation cephalosporins are rarely used in Swedish cattle (Växa Sverige, 
2015), we do not expect the prevalence of ESBL-producing E. coli to be much 
higher than what was observed. In addition, it was shown that the sensitivity of 
screening methods for ESBL-producing E. coli does not increase significantly 
by adding a pre-enrichment step (Diederen et al., 2012).     
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6 Conclusions 
The results from this thesis improve knowledge about the prevalence, risk 
factors, and spread of faecal AMR E. coli in preweaned dairy calves. Important 
conclusions are that: 
 Antimicrobial resistant E. coli strains are widespread among preweaned 
dairy calves in Sweden. The occurrence was strongly age-dependent, but 
was also associated with herd size, milking system, calf housing, and 
geographic location of the farm. Farm-level treatment with broad-spectrum 
antimicrobials increased the occurrence of faecal AMR E. coli in calves. 
Feeding WM to calves increased the proportion of faecal streptomycin and 
quinolone resistant E. coli in calves, but feeding WC had no effect on faecal 
AMR E. coli.  
 Waste milk and WC was fed to calves at least occasionally on a majority of 
surveyed farms. Farmers were more reluctant to feed TWM than WWM. 
Feeding WM to calves was in general more common on farms in southern 
than northern/eastern Sweden, on non-organic compared to organic farms, 
and on farms with tie stall barns compared to free stall barns. 
 Within-farm dissemination of QREC was correlated to the shedding of 
QREC by calves and post-partum cows. These calves and cows may have 
been colonized with QREC in the calving pen. The same QREC genotype 
was found in different sample types within the farm and on different farms, 
suggesting contagious spread of QREC within and between farms.  
 Fluoroquinolone treatment, WM feeding, and infrequent compared to 
frequent use of the calving pen as sick pen increased faecal QREC in 
calves, while group calving, poor farm hygiene, purchasing cattle or sharing 
animal transporter with other farmers increased faecal QREC in post-
partum cows. Moreover, the more purchased cattle, the higher was the 
QREC genetic diversity within the farm. Thus, proper within-and between-
farm biosecurity may be valuable to reduce the spread of QREC. 
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7 Practical recommendations 
The knowledge generated in this thesis can be used to define measures to 
reduce the burden of AMR E. coli on dairy farms. Here, some practical 
recommendations of the generated results are highlighted: 
 The use of broad-spectrum antimicrobials in the herd should be limited. In 
particular, we advise against the use of orally administered DHS in calves 
since the efficacy of these products in E. coli diarrhoea may be 
questionable, given the high prevalence of streptomycin resistance. 
Moreover, other broad-spectrum antimicrobials, such as fluoroquinolones 
should be avoided because the use of these drugs increases the prevalence 
of resistance.  
 Colostrum from cows treated with antimicrobials at drying off can be given 
to calves without increasing the prevalence of AMR E. coli, at least under 
Swedish conditions. However, milk from cows treated with antimicrobials 
during lactation should not be given to calves, not even during the 
withdrawal period. 
 Calving in single pen should be preferred over group-pen calving.  
 Improved farm hygiene, at least in the calving pens and in the feed and 
water troughs as well as milk feeding equipment in the calf pens, could 
potentially reduce the occurrence of AMR E. coli on the farm.  
 Reducing the number of epidemiological links between farms, such as 
purchase of cattle, may be important to reduce the spread of AMR E. coli. 
We therefore recommend that contacts that involve the spread of faecal 
material between farms should be minimized. 
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8 Perspectives for the future 
During this thesis work, some new questions that could be of interest in future 
studies were raised: 
Can the use of a commercial competitive exclusion product reduce the burden 
of AMR E. coli on dairy farms? 
If insufficient colonization resistance is a key factor in the establishment of 
AMR E. coli in the gut of calves, treatment with competitive exclusion 
products may be a way to reduce the burden of AMR E. coli. Competitive 
exclusion is when harmless bacteria, such as lactic acid bacteria, outcompetes 
harmful bacteria by competing for the same nutrients. The use of commercial 
competitive exclusion products has been associated with a reduction in ESBL-
producing E. coli in the broiler industry (Anderson et al., 1984; Nuotio et al., 
2013), reduction of diarrhoea cases in calves (von Buenau et al., 2005), and 
enterohaemorrhagic E. coli in weaned calves (Tkalcic et al., 2003). However, 
the ability of competitive exclusion products to reduce the shedding of AMR E. 
coli in calves has not been investigated and deserves attention in future 
research. If proven effective against colonization with AMR E. coli, such 
products could be given to calves and peri-partum cows after cleaning and 
disinfection of the calving pens. An example of such a product is the probiotic 
E. coli strain Nissle 1917, which is commercially available in Germany (von 
Buenau et al., 2005). 
Can prior betalactamase-treatment or fermentation of milk from penicillin-
treated cows lower the prevalence of faecal AMR E. coli in calves fed such 
milk? 
Because benzylpenicillin is used in the majority of systemic antimicrobial 
treatments of cows in Sweden, the bulk of WM that is fed to Swedish calves is 
likely to contain benzylpenicillin residues. If benzylpenicillin residues in WM 
can be inactivated, such milk can be a good nutrition source for calves. 
70 
Treatment of WM with a commercially available betalactamase enzyme 
(Antipen, Finnzymes, Oy, Finland) and fermentation of milk inactivate 
penicillin residues in WM. Three hours was sufficient for the betalactamase 
enzyme to inactivate all the penicillin in milk (Raustein, 2003), whereas 
fermentation of penicillin-milk took more time for inavtivation, at least when 
the concentration of penicillin residues in milk was high (Keys et al., 1976, 
1979). These tools may therefore be valuable to obtain penicillin-free WM that 
could be fed to calves. However, tudies on how the feeding of fermented or 
betalactamase-treated WM from penicillin-treated cows influences the 
shedding of AMR E. coli by calves are not available. Hence, a study that 
compares the occurrence of AMR E. coli in calves fed betalactamase-treated 
penicillin-milk, fermented penicillin-milk and untreated penicillin-milk would 
be valuable to find measures that reduce the risk of WM feeding.  
What is the farm-level clinical importance of having high prevalence of AMR 
E. coli in healthy dairy calves? 
Although the benefits of reducing the burden of antimicrobial resistance is 
relevant to the society as a whole, direct costs of measures to reduce the 
occurrence of AMR E. coli may be on the farm. Such measures may be 
difficult to implement on the farm if the farmer does not see any direct benefits 
of applying them. Therefore, it is necessary to evaluate the benefits of having 
low prevalence of AMR E. coli on the farm as compared to a high prevalence. 
Resistance in clinical E. coli isolates from the GI tract of calves seems to be on 
the rise in Sweden, with resistance to streptomycin or tetracycline occurring in 
76% of the isolates in 2013 (Swedres-Svarm 2013). It is logical to assume that 
a higher proportion of multidrug-resistant E. coli will be found in healthy 
calves on farms that have experienced GI infections with multi-drug resistant 
isolates than on farms with mostly susceptible clinical isolates, but this has so 
far not been investigated. Also, since resistant isolates more often carry 
virulence genes (de Verdier et al., 2012) than susceptible ones, it could be 
valuable to assess the association between the susceptibility of clinical isolates 
and the presence of virulence genes. Such a study could show potential farm-
level benefits of reducing the occurrence of AMR E. coli in healthy calves. 
Do widespread QREC genotypes possess characteristics that enhance their 
survival and spread compared to rare genotypes? 
In paper IV, we observed that some QREC genotypes seem to be more 
widespread within and between farms than other, rarer genotypes. This may be 
due to expression of factors that enhance their survival and spread. Studies in 
healthy humans have shown that QREC strains more often express virulence 
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traits, grow better in the main nutrient medium in the gut, and are more 
resistant to oxidative and acid stress than susceptible strains (Lastours et al., 
2014). Also, the fitness cost of resistance was dependent on the type of 
mutation conferring quinolone resistance (Gullberg et al., 2011). Hence, it 
could be of value to assess the genetic basis of resistance, the fitness, 
competitiveness in the gut, and survival in the farm environment of widespread 
compared to rare genotypes of QREC. 
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9 Populärvetenskaplig sammanfattning 
Bakgrund 
Antibiotika används för att behandla bakterieinfektioner hos människor och 
djur. Dock kan bakterier bli motståndskraftiga (resistenta) mot antibiotika, 
vilket kan leda till mycket svårbehandlade infektioner. Behandling med 
antibiotika kan leda till att resistens uppstår. Dessutom kan resistenta bakterier 
gynnas i förhållande till känsliga bakterier. Antibiotikaresistenta bakterier hos 
djur innebär inte bara en risk för djuren själva utan de kan också överföras till 
människor genom direktkontakt eller via livsmedel. Ett exempel på bakterier 
som kan överföras mellan djur och människor är Escherichia coli 
(kolibakterier) som finns i tarmen hos alla djur och människor. I normala fall 
vållar inte dessa kolibakterier några problem, men de kan ge sjukdom hos 
svaga individer. De här bakterierna kan även överföra resistensarvsanlag till 
andra bakterier som orsakar sjukdom, till exempel salmonella.  
I mjölkbesättningar bär unga kalvar oftare på resistenta kolibakterier i 
tarmen än äldre nötkreatur, trots att många av kalvarna inte har behandlats med 
antibiotika samt att kalvar och kor vistas i samma miljö. En teori till varför 
resistenta bakterier är så vanliga hos unga kalvar är att användningen av 
specifika antibiotika är hög i besättningen. Det kan till exempel vara en 
skillnad om man använder så kallade bredspektrumantibiotika, som verkar mot 
många sorters bakterier, jämfört med så kallade smalspektrumantibiotika, som 
endast verkar mot ett fåtal bakterietyper. Ett exempel på det sistnämnda är 
penicillin. Att ge kalvarna mjölk från antibiotikabehandlade kor är en annan 
teori till varför kalvar har så många resistenta kolibakterier. Sådan mjölk kan 
innehålla rester av antibiotika och får inte säljas till mejeriet varför den ibland 
ges till kalvarna istället. Få studier har dock gjorts om detta och man vet därför 
inte så mycket om varför resistenta kolibakterier är så vanliga hos kalvar. 
Eftersom kalvarna kan vara en viktig källa för resistenta bakterier för djur och 
människor är det viktigt att ta reda på vilka faktorer som har betydelse för 
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förekomsten samt spridningen av resistenta kolibakterier. Dessa kunskaper kan 
sedan användas för att ge rekommendationer om åtgärder för att minska 
förekomsten av resistenta bakterier i mjölkbesättningar. Av speciellt intresse i 
avhandlingen är resistens mot kinoloner som anses vara mycket viktiga för 
behandling av människor. 
Metoder och resultat 
Totalt fyra studier ligger till grund för avhandlingen. I den första studien var 
syftet att undersöka hur vanligt det är att råmjölk och mjölk från 
antibiotikabehandlade kor ges till kalvar i svenska mjölkbesättningar och om 
rutiner för detta skiljer sig åt mellan olika typer av gårdar. Detta undersöktes i 
en enkätstudie bland 457 besättningar. Resultatet visade att på 89 procent av 
gårdarna utfodrades kalvar någon gång med råmjölk (från första mjölkningen 
efter kalvning) från kor som antibiotikabehandlats vid sinläggning. 
Övergångsmjölk (från andra mjölkningen till och med fjärde dagen efter 
kalvning) från kor som antibiotikabehandlats vid sinläggning användes på 85 
procent av gårdarna. Mjölk från kor som behandlats med antibiotika under 
laktationen (mjölkgivningsperioden) gavs till kalvar på 56 procent (under både 
behandling- och karenstid) och 79 procent (enbart under karenstiden) av 
gårdarna. Överlag var det vanligare att man gav mjölk från behandlade kor på 
icke-ekologiska än ekologiska gårdar samt på gårdar med uppbundna kor 
jämfört med lösdrift eller gårdar som var belägna i södra Sverige jämfört med 
andra delar av landet.  
I den andra studien var syftet att undersöka hur förekomsten av resistenta 
bakterier skiljer sig åt mellan olika typer av gårdar och olika kalvar, samt hur 
användning av antibiotika och utfodring med mjölk från antibiotikabehandlade 
kor påverkar förekomsten av sådana bakterier. Avföringsprover från kalvar på 
243 gårdar runt om i Sverige samlades in och undersöktes för andelen 
streptomycin-, kinolon- och cefalosporinresistenta kolibakterier samt resistens 
mot olika antibiotika hos en slumpvist utvald kolibakterie. Resistens mot 
streptomycin var mycket vanlig, resistens mot kinoloner förekom på vissa 
gårdar, men resistens mot cefalosporiner var relativt ovanlig. Generellt sett var 
resistens vanligast vid en veckas ålder för att sedan gradvis minska hos 
kalvarna. Detta tros bero på att nyfödda kalvars tarmflora och immunförsvar är 
under utveckling och att resistenta bakterier därför lättare etablerar sig i 
tarmkanalen hos kalvar än hos äldre djur. Många resistenta kolibakterier har 
speciella egenskaper som ökar deras konkurrenskraft gentemot känsliga 
kolibakterier. Minskningen av resistenta kolibakterier med stigande ålder kan 
bero på en kombination av immunitet mot vissa kolibakterier samt ökad 
konkurrens från en mer utvecklad tarmflora. Att behandla kor eller kalvar med 
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bredspektrumantibiotika ökade förekomsten av resistenta kolibakterier hos 
kalvarna. De hade till exempel fler kinolonresistenta bakterier på gårdar där 
man behandlar med kinolonantibiotika jämfört med gårdar där man inte gör 
det. Däremot påverkade inte behandling med penicillin förekomsten av 
resistenta kolibakterier. Utfodring med råmjölk från kor som 
antibiotikabehandlats vid sinläggning gav inte upphov till fler resistenta 
kolibakterier hos kalvarna. Utfodring med mjölk från kor som behandlats med 
antibiotika under laktationen ökade däremot förekomsten av streptomycin- och 
kinolonresistenta kolibakterier. Antibiotika i mjölk hämmar antagligen 
känsliga mikroorganismer i tarmfloran och stör därmed balansen i tarmfloran, 
vilket i sin tur innebär att resistenta kolibakterier lättare etablerar sig i tarmen. 
Utfodring av kalvar med mjölk från kor som behandlats under laktationen kan 
därför inte rekommenderas ur resistenssynpunkt. 
Resistenta kolibakterier var vanligare på stora jämfört med små gårdar. Det 
fanns också skillnader i förekomsten av resistenta kolibakterier hos kalvar på 
gårdar med olika mjölkningssystem (vanligare på gårdar med mjölkgrop än 
robot eller uppbundna kor) samt på gårdar belägna i olika delar av landet. 
Exempelvis var kinolonresistens vanligare i södra och östra Sverige än i norra 
Sverige.  
I den tredje och fjärde studien studerades kinolonresistens lite närmare. 
Syftet med dessa studier var att undersöka förekomst och spridning av 
kinolonresistenta kolibakterier i gårdsmiljön och mellan gårdar samt att ta reda 
på vilka faktorer som har betydelse för förekomst och spridning av dessa 
bakterier. Dessa studier genomfördes på 23 gårdar som alla hade använt 
kinolonantibiotika, men som hade olika mycket kinolonresistenta kolibakterier 
hos kalvarna. På gårdar med en stor andel kinolonresistenta kolibakterier hos 
kalvarna hittades dessa bakterier ofta på väggar i kalvboxar, i kalvarnas 
fodertråg, vattentråg, och mjölkhinkar samt i kalvningsboxen, hos yngre 
ungdjur och i avföringsprov från nykalvade kor. Det kan därför antas att 
kinolonresistenta bakterier cirkulerar mellan individer på gården genom 
träckförorening av inredningen. Däremot verkar inte mjölk eller råmjölk vara 
en källa för kinolonresistenta kolibakterier för kalvarna. Resultaten tyder också 
på att kalvningsboxen kan utgöra en källa för kinolonresistenta kolibakterier 
för både kor och kalvar. 
På de flesta av de undersökta gårdarna var det samma typ av 
kinolonresistenta kolibakterier på olika ställen i gårdsmiljön, vilket tyder på 
dessa bakterier sprids inom gården. Faktorer som gynnade kinolonresistenta 
kolibakterier hos kalvarna var om man hade använt kinolonantibiotika i 
besättningen de senaste fyra månaderna, om man generellt sett utfodrar med 
mjölk från antibiotikabehandlade kor, och om kalven i fråga fått sådan mjölk 
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samt att sällan jämfört med ofta använda kalvningsboxen till sjuka kor. Det 
sistnämnda fyndet beror troligen på att kalvningsboxen tvättas oftare om man 
ofta ställer in sjuka kor i boxen. Fler kalvar bar dessutom på kinolonresistenta 
kolibakterier om minst en nykalvad ko av dem som undersöktes bar på dessa 
bakterier, vilket tyder på att förekomsten hos kalvar påverkas av eller påverkar 
förekomsten hos nykalvade kor. Kinolonresistenta kolibakterier var vanligare 
hos nykalvade kor om stallhygienen på gården bedömdes som sämre än 
genomsnittet i studien och om de hade kalvat i grupp. Detta indikerar att 
förekomsten borde kunna minskas genom ordentlig rengöring i kalv- (speciellt 
foder- och vattentråg) och kalvningsboxarna samt genom att låta kor kalva 
enskilt. 
Samma typ av kinolonresistenta kolibakterier hittades på mer än en gård, 
vilket tyder på att dessa bakterier kan spridas mellan gårdar. Gårdar som hade 
samma typ av resistent kolibakterie var belägna närmare varandra än gårdar 
som bara hade sina egna typer. Kinolonresistenta kolibakterier var vanligare 
hos nykalvade kor på de gårdar som brukar köpa in nötkreatur från andra 
gårdar eller som delar djurtransport med andra djurbönder. Dessutom var det 
fler olika typer av kinolonresistenta kolibakterier ju fler nötkreatur som hade 
köpts in under årens lopp, vilket tyder på att nya resistenta typer införs på 
gården via inköp av djur. Dessa resultat tyder på att kinolonresistenta 
kolibakterier sprids mellan besättningar, eventuellt genom inköp av nötkreatur 
och delad utrustning.  
Slutsatser och rekommendationer 
Sammanfattningsvis understryker resultaten vikten av ansvarsfull 
antibiotikaanvändning samt god hygien och gott smittskydd då dessa faktorer 
verkar ha betydelse för förekomsten och spridningen av resistenta kolibakterier 
inom och mellan gårdar. Följande rekommendationer kan ges utifrån studierna 
i denna avhandling: 
 Användningen av bredspektrumantibiotika bör begränsas och i första hand 
ska penicillin övervägas. 
 Råmjölk från kor som antibiotikabehandlats vid sinläggning kan ges till 
kalvar. 
 Mjölk från kor som behandlats med antibiotika under laktationen bör 
däremot inte ges till kalvar. 
 Kor bör i möjligaste mån kalva i enskilda boxar istället för gruppboxar. 
 Rengöring av kalvningsboxar samt inredningen i kalvboxar (speciellt foder- 
och vattentråg) kan troligtvis ge mindre resistens. 
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 Kontakter mellan gårdar som innebär att gödsel sprids från en gård till en 
annan, exempelvis inköp av djur eller att dela djurtransport med andra 
bönder, bör också i möjligaste mån undvikas. 
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